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      ABSTRACT 
 
 
AN EVALUATION OF SEDATION LEVEL USING BISPECTRAL INDEX (BIS) 
AND CORRELATED ADVERSE EVENTS IN PATIENTS UNDERGOING 
COLONOSCOPIES  
Paula M. Grey, RN, BSN and Jenna L. Poziombke, RN, BSN  
Western Carolina University (March 2014) 
Director: Dr. Mark A. Kossick 
 
 The purpose of this prospective, observational study was to provide data for 
anesthesia providers on current sedation practices during elective colonoscopies.  This 
included determining the incidence of general anesthesia (GA) and the presence or 
absence of correlated adverse events.  Additionally, this research considered if patients 
who are commonly consented for a MAC anesthetic should be more appropriately 
consented for GA.  
Participants (N = 39) consisted of a convenience sampling of physical status (PS) 
I, II, and III patients scheduled for elective colonoscopies and undergoing sedation with 
propofol.  Data was collected by researchers over a four-week period at a non-teaching 
rural hospital in Western North Carolina.  A bispectral index (BIS) monitor was used to 
monitor the depth of sedation and values were utilized to determine possible correlated 
adverse events. 
Statistical analysis showed that 100% (39/39) of patients reached levels of GA 
(i.e., BIS ≤ 60) at some point during their procedure.  Variables that showed a significant 
x 
correlation with the occurrence of GA were smaller body mass index (BMI) (r = -.42, r2 
= .17, p = .008), longer length of procedure (r = .85, r2 = .72, p < .001), and the number 
of minutes patients experienced an absent end tidal carbon dioxide (ETCO2) (i.e., apnea) 
waveform (r = .49, r2 = .24, p = .002).  Additionally, greater BMI correlated with a 
greater nadir BIS value obtained throughout the entire procedure (r = .54, r2 = .29, p < 
.001), and was found to correlate with less time at BIS values ≤ 40 (r = -.51, r2 = .26, p < 
.001).  Longer procedures correlated with more minutes spent with BIS values ≤ 40 (r = 
.43, r2 = .18, p = .007), and more minutes with absent ETCO2 waveform (r = .52, r2 = 
.27, p = .001); however, these findings were clinically insignificant since only one absent 
ETCO2 waveform actually resulted in a decrease in saturation of peripheral oxygen 
(SpO2) to ≤ 90% (i.e., hypoxia), which quickly resolved with a chin lift.  Additionally, 
the number of minutes with SpO2 ≤ 90% was not significantly correlated with the 
minutes of GA (r = -.17, r2 = .03, p = .299). 
The results of this study indicate, in patients scheduled for colonoscopies who are 
consented for IV GA, it is common for anesthesia providers to consistently deliver a level 
of sedation concordant with GA.  The significance of this finding relates to the pre-study 
clinical observation, that endoscopic patients being consented for anesthesia designated 
as MAC with IV sedation, actually demonstrate intraoperative signs of GA similar to 
what were observed in this study.  Future studies are warranted to determine the 
frequency of the various forms of anesthesia consent obtained for elective colonoscopies, 
along with research that assesses anesthetic depth with BIS monitoring in patients 
consented for MAC with IV sedation.  Such research would help to further enhance 
patient safety and address potential medical legal concerns.  
xi 
 
Keywords: Bispectral Index (BIS), colonoscopy, monitored anesthesia care (MAC), 
propofol sedation, adverse events.
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CHAPTER ONE:  BACKGROUND AND RATIONALE FOR STUDY 
 
 
Introduction 
 
Bispectral index (BIS) is frequently used as a monitor in the operating room to 
measure the depth of anesthesia and to help guide the titration of medications during 
general anesthesia (GA); however, it is not routinely used to monitor sedation levels and 
titrate medications during monitored anesthesia care (MAC) with intravenous (IV) 
sedation during endoscopic procedures.  Although there have been some studies in non-
anesthesia journals that have looked at the use of BIS as an adjunctive monitor for 
titrating a patient’s sedation level with sedatives and anxiolytics (Bell et al., 2004; Drake, 
Chen, & Rex, 2006; Hata et al., 2009), there is limited research that has evaluated BIS 
values in patients undergoing sedation given by anesthesia providers for colonoscopies.  
The most extensively researched electroencephalogram (EEG) device currently 
used to evaluate depth of anesthesia is BIS (Bruhn et al., 2003; Cortínez, Delfino, 
Fuentes, & Muñoz, 2007; Doufas et al., 2003; Ge, Zhuang, Y. Wang, Z. Wang, & Li, 
2002; Kearse et al., 1998); it has also been shown to be useful with measuring sedation 
levels during endoscopic procedures (Bell et al., 2004; Hata et al., 2009; Leslie, Absalom, 
Kenny, 2002).  Several studies have shown that GA, or deeper levels of sedation than 
intended, frequently occur during IV sedation (Drake et al., 2006; El Chafic, Eckert, & 
Rex, 2012; Patel et al., 2005; Sieber, Gottshalk, Zakriya, Mears, & Lee, 2010).  One 
prospective, mixed-design study showed that 87% of elderly patients undergoing 
propofol-based sedation combined with spinal anesthesia, experienced GA (i.e., a BIS 
value ≤ 60) (Sieber et al., 2010).  In another prospective study with an observational 
design, it was shown that 76% of participants undergoing endoscopic sedation were 
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unresponsive to "deep stimuli" (El Chafic et al., 2012).  It has also been demonstrated 
that deeper levels of sedation during endoscopic procedures leads to an increase in 
complications such as aspiration, apnea, hypoxia, airway obstruction, respiratory distress, 
hypotension, and bradycardia (Arrowsmith, Gerstman, Fleischer, & Benjamin, 1991; 
Froehlich et al., 1997; McCloy, 1992; Sharma et al., 2007; Sieber et al., 2010).  
According to the American Society for Gastrointestinal Endoscopy (ASGE) (2007), 
colonoscopy remains the most effective screening option for colorectal cancer with 
approximately 14.2 million colonoscopies performed in the US in 2002 (Seeff et al., 
2004).  Therefore, the research findings of this thesis could potentially impact a 
significant number of patients and healthcare providers. 
Purpose Statement 
The purpose of this prospective, observational study was to evaluate the level of 
sedation achieved during the delivery of anesthesia services in patients scheduled for 
elective colonoscopies; this included determining the incidence of GA and correlated 
adverse events.  Additionally, the researchers attempted to assess if this patient 
population should be consented for GA versus MAC with IV sedation; given the pre-
study clinical observation and literature finding of colonoscopy patients being 
increasingly consented for MAC with IV sedation (Cohen & Benson, 2009; Cohen et al., 
2006; Inadomi, Gunnarsson, Rizzo, & Fang, 2010; Rex, 2011; Siddiqui, Shafiq, & 
Asghar, 2012; Trummel, 2007).  Consequently, the outcomes of this study could have 
patient safety, medical-legal, and potential reimbursement implications.  
Dependent variables for this study were recorded in the preoperative holding area, 
procedure room, and post anesthesia care unit (PACU).  They included BIS values, 
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saturation of peripheral oxygen (SpO2) via pulse oximetry, oxygen delivery devices 
(e.g., nasal cannula [NC], non-rebreather mask), any required intraoperative changes in 
liters of oxygen flow from baseline oxygen flow rates, if measured, the presence or 
absence of end tidal carbon dioxide (ETCO2), the number of airway assistance maneuvers 
(including but not limited to, chin lift, jaw thrust, combination of chin lift and jaw thrust, 
nasopharyngeal airway insertion, oropharyngeal airway insertion, and laryngeal mask 
airway [LMA] placement), heart rate (HR), systolic blood pressure (SBP), diastolic blood 
pressure (DBP), mean arterial pressure (MAP), temperature, and respiratory rate (RR).  
Justification of the Study 
 Only a paucity of data has been found in the anesthesia literature as it relates to 
BIS monitoring for patients scheduled for colonoscopies.  As noted earlier, the 
significance of this research can potentially impact a substantial number of anesthesia 
providers and patients, given that over 14 million colonoscopies were estimated to be 
administered in the US in 2002 (Seeff et al., 2004).  Additionally, the use of sedation for 
endoscopic procedures continues to increase throughout the world (Cohen et al., 2006) 
and there has been a significant growth in the number of endoscopic procedures being 
performed by anesthesia providers (Liu, Waxman, Main, & Mattke, 2012). 
 Furthermore, it is recognized that some anesthesia departments choose to consent 
patients for MAC with IV sedation instead of GA for elective colonoscopies.  The latter 
form of anesthesia carries with it an increased risk for complications (Bell et al., 2004; 
Bhanaker et al., 2006; Petrini & Egan, 2004), especially in patients with significant 
comorbidities (Behrens et al., 2013; Bell et al., 2004; Sharma et al., 2007).  Thus, if 
research reveals a GA state is being achieved with propofol dosages used by some 
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anesthesia providers during MAC with IV sedation, then a change in the consenting 
process may very well be indicated; which could potentially enhance patient safety (alter 
preoperative risk assessment), as well as have medical-legal implications (obtaining 
informed consent). 
Scientific Rationale  
Non-randomized, observational studies (NROS) involve viewing unmodified 
practice conditions and may represent a more realistic or accurate view of outcomes 
under these real-world conditions (Biddle, 2013).  NROS may be the only means for a 
researcher to study a specific variable of interest or problem in their field of work as well 
as the only way to validate findings in the literature (Whittemore & Grey, 2006).  
Although there have been some studies that have used BIS monitoring to titrate or assess 
a patient's sedation level during MAC anesthetics or conscious sedation (Bang et al., 
2013; Drake et al., 2006; Hata et al., 2009; Sieber et al., 2010; Verma, Paswan, Prakash, 
S. Gupta, & P. Gupta, 2013), there has been no research that has quantified sedation 
levels via the BIS monitor in patients undergoing MAC with IV sedation or GA during 
elective colonoscopies.  
Viewing actual practice conditions is important for collecting data that 
randomized controlled trials may not interpret correctly in certain scenarios (Black, 
1996).  Observational research is a type of correlational study that has many advantages 
such as: the ability to collect a vast amount of information in an area of interest, the 
capacity to examine the existence and strength of relationships between variables, and the 
potential to use results as a framework for future experimental studies (Whittemore & 
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Grey, 2006).  Furthermore, observation of real-life practices can lead to the 
identification of previously unrecognized issues and the development of new research 
questions. 
Assumptions 
 1. Anesthesia providers accurately documented the total doses of propofol given 
on the anesthetic record. 
 2. Patient's medication list was accurately recorded to assess whether patients 
were taking any medications that could have skewed BIS values. 
 3. Any preoperative sedation medications given were accurately charted by the 
anesthesia provider and/or nurse. 
 4. A patient's history of a neurological disorder such as dementia or Alzheimer's 
disease was accurately recorded on the surgeon's and/or endoscopist's history and 
physical note or anesthesia provider's pre-anesthetic assessment form. 
Research Questions 
The research questions this study intended to answer were: 
 1. What is the frequency of producing a general anesthetic state, as defined by a 
BIS value ≤ 60, during elective colonoscopies in physical status (PS) I, II, and III 
patients?  
 2. Is there an association between GA (i.e., BIS value ≤ 60) and adverse 
perioperative and/or postoperative events (e.g., apnea, desaturation) in PS I, II, and III 
patients who undergo an elective colonoscopy procedure? 
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 3. Does a relationship exist between the anesthesia providers' years or months 
of experience and depth of sedation achieved (as determined with BIS values) relative to 
the planned anesthetic? 
 4. Should patients who undergo an elective colonoscopy be more appropriately 
consented for GA versus MAC with IV sedation? 
Definition of Terms  
• GA: a state of loss of consciousness in patients produced by IV sedative 
medications or inhalational gases where patients are unresponsive to the painful 
stimulus of surgery.  Patients usually require assistance with producing a patent 
airway by placement of an LMA or endotracheal tube and may also require the 
use of vasoactive drugs to support the cardiovascular system. 
• MAC: when an anesthesia provider is required to monitor the physiological status 
of patients undergoing a diagnostic or minor procedure such as a colonoscopy or 
lump excision. 
• MAC with IV sedation: When anesthesia providers administer sedation 
medications during MAC, including but not limited to, IV sedative and anxiolytic 
drugs.  Patients' sedation can range from minimal to deep at the discretion of the 
anesthesia provider to keep the patient comfortable during the procedure. 
• Sedation: a state of decreased consciousness that can range from minimal to deep 
produced by titration of sedative or anxiolytic medications.  Patients may need 
assistance with breathing, maintaining a patent airway, and cardiovascular 
function. 
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• Comorbidities: major disease processes or conditions that are in addition to the 
patient's primary diagnosis.   
• PS I: a healthy patient, also sometimes referred to as American Society of 
Anesthesiologists (ASA) I. 
• PS II: a patient with mild systemic disease and no functional limitations, also 
sometimes referred to as ASA II. 
• PS III: a patient with moderate to severe systemic disease resulting in some 
functional limitations, also sometimes referred to as ASA III. 
• PS IV: a patient with severe systemic disease that is a constant threat to life and 
results in significant functional limitations, also sometimes referred to as ASA IV. 
• PS V: a patient who is not expected to live 24 hours with or without having 
surgery, also sometimes referred to as ASA V. 
• Dependent variables: BIS values, SpO2, oxygen delivery device (e.g., NC, non-
rebreather mask), any required intraoperative changes in liters of oxygen flow 
from baseline oxygen flow rates, ETCO2 presence or absence if measured, the 
number of airway assistance maneuvers (including but not limited to, chin lift, 
jaw thrust, combination of chin lift and jaw thrust, nasopharyngeal airway 
insertion, and oropharyngeal airway insertion, LMA placement), HR, SBP, DBP, 
MAP, temperature and RR in the preoperative holding area and PACU. 
• Independent variables: the anesthesia provider, total propofol dose and total 
dosages of any other medications given preoperatively and intraoperatively. 
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CHAPTER TWO:  REVIEW OF THE LITERATURE 
 
 
Endoscopy and Sedation 
 
 According to the ASGE, colonoscopy remains the most effective screening option 
for colorectal cancer, and the number of colonoscopies performed each year in the United 
States has significantly increased.  In 2000, 19.1% of all adults aged 50 to 75 years old 
underwent a colonoscopy for screening; this increased to 54.9% in 2010 (National Center 
for Health Statistics, 2013).  Furthermore, the use of sedation during endoscopy continues 
to increase throughout the world (Cohen et al., 2006).  Sedation during endoscopy is 
often administered in an office or outpatient setting by nurses under the supervision of an 
endoscopist	  (Cohen et al., 2006).  However, over the past several years there has been a 
substantial growth in the number of endoscopic procedures that incorporate procedural 
sedation performed by anesthesia providers, specifically from 14% in 2003, to more than 
30% in 2009, and over 66% of these patients were not high risk (i.e., PS I or II) (Liu et 
al., 2012).  During this time period, Medicare payments for endoscopic procedures 
doubled and payment from private insurance companies quadrupled, prompting debate 
about which patients should and should not receive anesthesia services for endoscopic 
procedures (Liu et al., 2012).  Furthermore, by 2015, anesthesia providers are predicted to 
provide sedation for over 50% of all colonoscopies (Inadomi et al., 2010).  Currently, due 
to the added costs of anesthesia services, it is agreed upon by major insurers (such as 
Aetna) that anesthesia services for endoscopic procedures is acceptable for high risk 
patients only (e.g., PS III or greater, age < 18 or ≥ 70, “prolonged” or “complex” 
procedures, pregnancy, intolerance to sedative medications, uncooperativeness, agitation, 
history of drug or alcohol abuse, epilepsy, anatomic abnormalities that may increase risk 
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for airway obstruction) (Aetna, 2007).  The Centers for Medicare & Medicaid Services 
(CMS) as well as UnitedHealthcare have also reaffirmed their insurance coverage for 
propofol use in colonoscopies by anesthesia professionals or gastrointestinal endoscopists 
(Centers for Medicare & Medicaid Services [CMS], 2011b; UnitedHealthcare, 2008). 
 With nurse-administered sedation, midazolam and fentanyl are often used.  These 
agents, when titrated appropriately, are typically considered safe for producing a “light” 
level of sedation and patients are usually still able to respond to painful stimuli and 
maintain airway reflexes.  Sometimes, nurses administer propofol (Diprivan) for sedation 
under the direction of a gastroenterologist.  This is a controversial practice since patients 
can unintentionally reach deep levels of sedation, including GA.  The 2011(b) 
recommendations from the ASA state that any healthcare provider administering propofol 
for sedation should be trained in providing GA.  In addition, the manufacturer of propofol 
lists the following on the package insert:	  “for GA or MAC sedation, Diprivan Injectable 
Emulsion should be administered only by persons trained in the administration of GA and 
not involved in the conduct of the surgical/diagnostic procedure” (Hospira, 2009).  
Nevertheless, one large (N = 646,080) retrospective study argued that MAC with IV 
sedation is more expensive than endoscopist-directed propofol administration and that 
MAC with IV sedation does not result in any increased safety for routine endoscopic 
procedures in average-risk patients (Rex et al., 2009).  A 2006 nationwide survey also 
found that endoscopists were more satisfied with sedation from propofol rather than 
sedation with a benzodiazepine combined with a narcotic.  The reasons given for this 
preference included: better sedation, superior analgesia, reduced recovery time, faster 
return to usual activity, and improved quality of endoscopic examination (Cohen et al., 
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2006).  One large (N = 756), prospective, multicenter clinical trial suggested utilizing 
anesthesia personnel for gastrointestinal (GI) endoscopic procedures because patients 
were found to be significantly more satisfied (p < .0001) when anesthesia personnel were 
employed (Iravani et al., 2012).  Additionally, a Cochrane review of propofol sedation 
during colonoscopies found that the use of propofol for sedation during colonoscopy 
procedures in healthy patients (unspecified age range) can speed recovery, quicken 
discharge times, and improve patient satisfaction without producing a greater frequency 
of adverse events (Singh et al., 2008).  
 Understanding sedation levels can be an area of confusion since GA can be 
regarded as a stage of sedation or as a level of anesthesia on a continuum (American 
Society of Anesthesiologists [ASA], Task Force on Sedation and Analgesia by Non-
Anesthesiologists, 2002).  For this observational study, GA will be considered a stage of 
sedation unless otherwise stated.  Sedation will be defined as a drug induced depression 
in the level of consciousness consisting of four stages: minimal sedation (anxiolysis), 
moderate sedation, deep sedation, and GA (ASA, Task Force on Sedation and Analgesia 
by Non-Anesthesiologists, 2002).  All patients receiving “anesthesia” (stage not 
specified) should have oxygenation, ventilation, and circulation monitored, and body 
temperature should be assessed if clinically significant changes are anticipated (ASA, 
2011a).  The ASA, in a position statement updated in 2009, further clarified these terms.  
This document defined and categorized levels of sedation as minimal, moderate, deep, 
and GA.   
• Minimal sedation: drug induced anxiolysis with no alteration in response to verbal 
stimuli and no alteration in cardiovascular, respiratory, or ventilatory function 
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• Moderate sedation: is synonymous with conscious sedation and represents a 
drug-induced depression of consciousness during which patients respond 
purposefully to verbal command (with or without light tactile stimulation) and are 
able to maintain a patent airway without intervention, sustain adequate 
spontaneous ventilation, and usually maintain their cardiovascular function 
• Deep sedation: a drug-induced depression of consciousness during which patients 
cannot be easily aroused but can respond purposefully to repeated or painful 
stimulation; independent ventilatory function may be impaired, airway assistance 
may be required to maintain airway patency, and spontaneous ventilation may be 
inadequate; cardiovascular function is usually maintained  
• GA: a drug-induced loss of consciousness during which patients are not arousable 
even by painful stimulation, the ability to maintain independent ventilation is 
usually impaired, assistance is often needed to maintain a patent airway, positive 
pressure ventilation may be needed, and cardiovascular function may be 
compromised  
 The ASA in 2013 defined MAC as including varying levels of sedation (i.e., 
minimal, moderate, or deep), but also indicated if a patient becomes unconscious and the 
ability to respond purposefully is lost, GA has consequently occurred regardless of the 
need for airway instrumentation.  For clarification, there remains in the literature 
inconsistency with the use of the acronym MAC.  Some authors reference this 
abbreviation to be synonymous with MAC with IV sedation; while others view MAC as 
representing the monitoring of diverse physiologic parameters without the concurrent use 
of IV sedatives.  
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 Propofol has a rapid onset and fast recovery time, making it the most 
commonly used agent for producing minimal and moderate sedation during endoscopy 
procedures (American Society for Gastrointestinal Endoscopy [ASGE], Standards of 
Practice Committee, 2008; Cohen et al., 2007; Zakko, Seifert, & Gross, 1999).  Propofol 
based sedation in GI endoscopy procedures increased to 26% of the total U.S. volume by 
2006 (Cohen et al., 2006) and a recent study projected that propofol will be used in 53% 
of endoscopy cases by 2015 (Inadomi et al., 2010).  Decreased myocardial contractility 
and respiratory depression are sometimes seen with the use of propofol; however, these 
effects can usually be reversed by stopping the infusion or by decreasing the dose (Cohen 
et al., 2007). 
 The ASGE Standards of Practice Committee (2008) provides updated guidelines 
for sedation during GI endoscopy.  They state that sedation for these procedures is patient 
specific, ranging from no sedation at all to GA.  Moderate sedation, as defined by the 
ASA, is usually considered adequate for routine, uncomplicated GI endoscopy 
procedures.  The guidelines further indicate that if propofol is being used for sedation 
during these procedures, then physiologic monitoring should be incorporated and include 
the use of pulse oximetry, electrocardiogram (ECG), and intermittent blood pressure (BP) 
measurements.  Capnography should also be considered because it may decrease the risks 
associated with deep sedation (Nelson et al., 2000).  Propofol can be titrated to moderate 
sedation when combined with low doses of opioids and benzodiazepines, but since deep 
levels of sedation can quickly occur when propofol is used with or without these sedative 
agents, providers should always be prepared for deep sedation (Cohen, Hightower, 
Wood, Miller, & Aisenberg, 2004; Rex, 2011; VanNatta & Rex, 2006).  This further 
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confirms the occurrence of deep sedation when propofol is used for sedation.  Overall, 
the ASGE Standards of Practice Committee recommends always focusing on maximizing 
patient comfort while minimizing risk during GI endoscopy procedures.  
 Additional sedation recommendations were provided by the American	  
Gastroenterological Association Institute after completing a review of endoscopic 
sedation in 2007 (Cohen et al., 2007).  This article was designed to standardize the 
practice of endoscopic sedation.  Similar to the previous article from the ASGE Standards 
of Practice Committee, it was suggested that the overall goal of endoscopic sedation is to 
keep the patient comfortable without producing side effects from drug administration.  
They emphasized that endoscopy monitoring should not only include physiologic 
assessment (e.g., BP, HR, SpO2) but visual assessment (e.g., grimacing, movement) as 
well because the latter can often identify potential complications sooner than physiologic 
monitoring. 
Comparable Research 
 Only a few researchers have evaluated the use of BIS monitoring during MAC 
anesthetics with IV sedation or conscious sedation (Drake et al., 2006; Hata et al., 2009; 
Sieber et al., 2010).  These studies are diverse in their findings and difficult to compare 
since there is large variability in their designs.  Additional research using the BIS monitor 
during MAC with IV sedation during endoscopic procedures could lead to a clearer 
understanding of the sedation levels (and perhaps unintended GA) actually achieved. 
 In an attempt to evaluate the usefulness of BIS monitoring in patients undergoing 
endoscopic submucosal dissection for removal of neoplasms from the digestive tract, one 
randomized controlled trial was conducted over a three-year period (Hata et al., 2009).  A 
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total of 366 patients were included in the study.  Propofol was titrated to a pre-
determined BIS value; 56 to 65 in one group of patients, and 70 to 75 in another group of 
patients.  All patients received 2 L/min of oxygen via NC, and pentazocine (Talwin) 15 
mg via continuous IV infusion (unspecified duration) immediately preceding initiation of 
sedation.  A propofol bolus of 40 mg was then administered to all patients, followed by a 
continuous infusion at 50 mcg/kg/min, and was titrated by an anesthetist or an 
“endoscopy specialist trained in anesthesia” to maintain desired BIS values.  Pulse 
oximetry, BP and three lead ECG were monitored at unspecified intervals.  Data analysis 
showed that 3.6% of subjects (13/366) in the 56 to 65 BIS range experienced adverse 
events: six had bradycardia (HR <50 bpm), four had hypotension (SBP < 90 mmHg), two 
had respiratory depression (patient needing mandatory ventilation), and one experienced 
delayed awakening (patient did not awaken within 15 minutes after propofol 
discontinuation).  There were no adverse events when propofol was titrated to BIS values 
between 70 and 75.  This study concluded that BIS is useful for the safe performance of 
endoscopic submucosal dissection when propofol is titrated to a BIS value between 70 
and 75.   
 The methodology of this study had significant limitations.  The first of these being 
there were no baseline BIS values recorded.  This limitation made it difficult to determine 
the actual percent change in BIS values between the non-sedated and sedated states, and 
how that may have correlated with adverse events.  There was also no mention of other 
airway interventions, such as jaw thrust or chin lift, so it is unclear how many participants 
in the study experienced obstruction of their airway.  Furthermore, there was no 
predetermined sample size for each group.  Instead, when adverse effects started to occur 
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in the first group of patients (BIS values maintained at 56 to 65), data collection for 
that group stopped, and the target BIS value was increased.  Data collection was then 
initiated for the second group (BIS values maintained at 70 to 75).  Consequently, 
maintaining BIS values between 56 and 65 could have led to a higher number of recorded 
adverse events if data were collected on a pre-determined number of patients.  Other 
limitations included the lack of statistical consideration for PS classification, the omission 
of p values, and failure to report the length of the procedure or exclusion criteria.  In 
general, the study suggested a greater number of adverse events may occur in patients 
undergoing endoscopic submucosal dissection procedures when BIS values are 
maintained between 56 and 65.  
 Research has shown that BIS values ≤ 60 are consistent with a state of GA (Bell 
et al., 2004; Cortínez et al., 2007; Drake et al., 2006; Hata et al., 2009).  The BIS pocket 
guide and other publications have also indicated that BIS values between 40 and 60 
correlate with GA (Johansen, 2006; Kelley, 2010).  One prospective, mixed design study 
examined elderly (> 65 years old) patients undergoing spinal anesthesia with sedation 
using propofol during repair of hip fractures (Sieber et al., 2010).  The focus of this 
research was to determine if sedation in this patient population was equivalent to GA via 
BIS monitoring (values ≤ 60).  Forty elderly patients undergoing repair for hip fractures 
were enrolled in the study.  Additional criteria for participant selection were not provided 
by the researchers, and specific comorbidities were not discussed.  The 40 subjects were 
divided into a control group (n = 15) that had no alteration in standardized practice or the 
way drugs were administered, and an intervention group (n = 25) that had propofol 
titrated based on an alertness and sedation scale, known as the observer’s assessment of 
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alertness/sedation (OAA/S) (see Appendix A).  The OAA/S is an assessment tool used 
to subjectively gauge the level of sedation on a five point scale; the lowest score on the 
scale is 0 and indicates no response to noxious stimuli, and the highest score is 5 and 
indicates the patient responds to their name spoken in a normal tone.  The goal with the 
intervention group was for the anesthesiologist to maintain a minimum level of sedation 
by keeping the participant at a sedation level of 4 (i.e.,	  lethargic response to name spoken 
in a normal tone) or 5 on the OAA/S scale.  Scores were measured every 5 minutes, and 
if the OAA/S score was < 4, the propofol infusion was reduced.  Both groups had BIS 
monitoring throughout the surgical procedure, which was compared between groups to 
determine how much time was spent in a state of GA, defined as a BIS value ≤ 60.  
Results showed that the control group, which had no alteration in propofol administration 
in response to an OAA/S score, had 86.7% (13/15) of its participants experience sedation 
levels consistent with GA (BIS values ≤ 60).  The control group also spent a mean 
surgical time of 32.2% at BIS values consistent with GA.  In the intervention group, the 
OAA/S scale was used to maintain minimal sedation.  Propofol was the primary sedative 
and was administered along with fentanyl as needed.  With this group, 44% (11/25) of 
participants experienced GA for at least 1 minute, and spent a mean surgical time of 5% 
with BIS values consistent with GA (p < .001).  The number of anesthesiologists 
participating in the study was not disclosed; however there was not a significant 
difference (p = .797) in the dosing of fentanyl in the control group (1.3 mcg/kg ± 1.0 
mcg/kg) and in the intervention group (1.5 mcg/kg ± 2.6 mcg/kg).  There was also no 
significance in the distribution of the various PS classifications between groups (p = 
.486), level of spinal anesthesia (p = .693), or length of surgery (p = .067).  A significant 
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difference was found for the following variables in the intervention group: lower 
propofol dose (p = .014), older patients (p = .049) (83 ± 7 in the intervention group vs. 78 
± 8 in the control group), and lower midazolam dose (p = .002).  Statistical analysis also 
showed a significant difference (p < .001) in the amount of surgical time spent at sedation 
levels consistent with GA (BIS ≤ 60) in the control group versus the intervention group.  
It was concluded that GA occurs frequently in elderly patients undergoing spinal 
anesthesia combined with propofol sedation, and titrating propofol to a previously 
determined BIS value range decreases this occurrence.  
 Unfortunately, the investigators did not report their exclusion criteria, or the 
technique used for administering propofol (e.g., infusion, bolus, combination of infusion 
and bolus), which decreased the external validity of this study.  Furthermore, internal 
validity was weakened because there may have been failure to exclude patients with 
potential alterations in baseline BIS values (e.g., cerebrovascular accident [CVA], 
dementia).  In spite of these limitations, this research seems to offer some evidence that 
GA commonly occurs in elderly patients undergoing spinal anesthesia with propofol 
sedation for repair of hip fractures.  Furthermore, this study provides an impetus for 
additional research into the occurrence of unintended GA in other patients scheduled for 
surgery or diagnostic procedures.  
 Of interest during the literature review was the discovering of only one study that 
suggested there is no benefit to using BIS monitoring with propofol sedation for 
colonoscopies (Drake et al., 2006).  This was a randomized control trial that evaluated the 
usefulness of BIS monitoring as an adjunct to nurse-administered propofol sedation 
during colonoscopy procedures.  Effectiveness was determined by measurements of 
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reduction in recovery time and total doses of propofol administered to patients.	  	  All 
study participants (N = 102) underwent an elective colonoscopy and were over 18 years 
old with a PS classification of I or II.  The two nurses and one endoscopist participating 
in this study were said to have had “several years” of endoscopy experience.  Participants 
were randomly divided into one of two phases (see Table 1), each consisting of an 
intervention group and a control group.  In phase 1 (n = 47) and phase 2 (n = 55), the 
endoscopist teams (i.e., one of the two nurses administering the propofol and the 
endoscopist) were randomly assigned to either the control group (n = 24, phase 1; n = 26, 
phase 2) or the intervention group (n = 23, phase 1; n =29, phase 2).  For the control 
group in both phases, the endoscopist teams were blinded to BIS values, and were 
instructed to titrate sedation as they normally would within their routine practice.  This 
included considerations for physiologic changes (i.e., HR, BP, ventilatory effort) and 
subjective assessment of patient discomfort, undesired movement, and the modified 
observer's assessment of alertness and sedation (MOAA/S) scale (see Appendix B).  In 
the intervention group of phase 1 the endoscopy team was not blinded to BIS values.  
They were instructed to only use BIS values as an “adjunctive tool” and to avoid titration 
of propofol in response to BIS values.  At the end of phase 1, the researchers conducted 
analysis before proceeding into phase 2.  They found no difference in propofol dose (p = 
.45) or recovery times (p = .34) with the blinded (control) versus non-blinded 
(intervention) groups.  Just as in phase 1, the endoscopy team was blinded to BIS values 
in the control group for phase 2 and were instructed to titrate sedation as they normally 
would within their routine practice.  In the intervention group of phase 2, BIS was used as 
the primary endpoint for sedation with a target value of 60 to 70 (i.e., deep sedation).  
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The endoscopy team was instructed to refrain from giving propofol boluses when BIS 
values were < 60, except when the patient was believed to be experiencing significant 
discomfort or moving enough to interfere with the procedure.  For all patients, in both 
phase 1 and phase 2, propofol was the only sedative agent administered and all patients 
received an initial 40 mg bolus, followed by incremental boluses of 10 to 20 mg.  BIS 
values, HR, SpO2, and 3-lead ECG were recorded continuously on all patients, but it was 
not stated how often these variables were documented.  Additionally, a baseline BP was 
obtained, followed by BP recordings every 5 minutes, and the total dose of propofol was 
documented.  Vital sign recordings were continued in the PACU for up to 1 hour or until 
discharge, whichever came first.  
Table 1 
 
Study Design Characteristics   
     
Group  Phase 1 
n      BIS value 
 Phase 2 
n      BIS value 
  
Controla    24      Blinded                         26      Blinded 
 
Intervention    23      Used as            29    Targeted to  
         "adjunctive tool"                             60-70 with  
          and not used for         propofol 
          propofol titration  
__________________________________________________________________________________________________ 
Note. N = 102. BIS = bispectral index 
aSedation titrated according to routine practice 	  
 
 Statistical analysis for both phase 1 and phase 2 showed no significant difference 
between intervention and control groups in average BIS values (p = .82, phase I; p = .57, 
phase II), sedation levels (p values not provided) using the MOAA/S scale (see Appendix 
B), propofol dose (p = .45, phase I; p = .92, phase II), recovery time (p = .34, phase I; p = 
.27, phase II), or	  complications.  There were no significant differences found between 
phase 1 and phase 2 in regards to patient satisfaction or recall, however, there were no p 
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values provided to validate the accuracy of this finding.  Oxygen desaturation, defined 
as an SpO2 < 90%, occurred in 2.9% (3/102) of patients and resolved with a chin lift 
maneuver, deep breathing, or cessation of propofol administration.  The phase or phases 
in which these adverse events occurred was not specified by the investigators.  Patients 
were found to “regularly” experience BIS values consistent with GA during “some part” 
of the procedure, but the investigators did not offer any defining characteristics or exact 
frequency of this occurrence.  Furthermore, the researchers postulated the possibility that 
there was no apparent benefit from monitoring with BIS because the endoscopy nurses 
were already very experienced with propofol administration when the study began.  This 
acknowledgement suggests the endoscopist team assigned to the Phase 2 intervention 
group may have allowed their propofol titration bias to disregard the prescribed 60 to 70 
BIS target value.  Lastly, the investigators acknowledged that the sample size was not 
sufficient to rule out a safety benefit of BIS.  
Deep Sedation Occurs with Endoscopy 
 In clinical practice, it is possible that deep sedation occurs during endoscopy 
procedures.  Some studies have specifically identified this occurrence and the potential 
associated adverse events	  (El Chafic et al., 2012;	  Patel et al., 2005;	  Soto, Fu, Smith, & 
Miguel, 2005).  In 2012, one such study examined the intra-procedural incidence of 
coughing, hemodynamic changes, and oxygen desaturation and their correlation with 
clinical factors and sedation (El Chafic et al., 2012).  Although BIS was not used to 
provide objective data, there was subjective validation of deep sedation occurring during 
endoscopy procedures.  This prospective observational study involved a total of 747 
consecutive patients undergoing nonemergent endoscopy procedures (El Chafic et al., 
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2012).  These procedures consisted of esophagogastroduodenoscopy (EGD) (n = 254), 
colonoscopy (n = 338), combination of colonoscopy and EGD (n = 80), endoscopic 
ultrasonography (EUS) (n = 65), and others, which were comprised of mostly push 
enteroscopy and deep small bowel enteroscopy (n = 20).  Patients were sedated with 
propofol, and/or midazolam, and/or fentanyl by a registered nurse under the supervision 
of an endoscopist.  Specific dosages and method of delivery (e.g., infusion, bolus) of 
sedative medications and opioids were not provided, but 63% (476/747) received a 
combination of propofol, midazolam and fentanyl; 26% (197/747) received a 
combination of fentanyl and midazolam; 9% (66/747) received propofol only; 1% 
(10/747) received propofol and midazolam; and 1% (5/747) received propofol and 
fentanyl.  Data recording included: BP every 5 minutes, HR and sedation levels every 2 
minutes, and SpO2 every minute.  All patients received oxygen via NC at 4 L/min.  
Sedation level was determined by using a subjective tool known as the MOAA/S scale 
(see Appendix B).  The MOAA/S scale ranges from 0 to 6, with values ≤ 1 being 
considered deep sedation, however the scale provides no assessment of GA.  Seventy 
eight percent (593/757) of patients were reported by the researchers to have experienced 
deep sedation (i.e., MOAA/S ≤ 1) or GA (undefined) during their procedure.  Twenty 
four percent (181/757) of patients were smokers with or without COPD, 8% (59/757) had 
asthma, 5% were smokers and had asthma (37/757), and 63% (480/757) did not have 
respiratory disease.  
 Oxygen saturation dropped from baseline (values not provided) more than 4% in 
95% of patients, with 4% dropping below 90% saturation and 2% dropping below 85% 
saturation.  No data was provided indicating the existence of a correlation between 
 
	   33 
decreases in SpO2 and medication administration times.  However, “deeper” sedation 
was found to be the only significant risk factor for a decline in SpO2 to below 90% (p = 
.02).  Mean SBP dropped an average of 7.3%, and DBP declined an average of 5.6%, 
with all changes resolving spontaneously, but within an unspecified amount of time.  
Regardless of dose and type of agents used, there was an 8.53% greater decrease in SBP 
with colonoscopy procedures than all other procedures combined (p < .0001).  Thirteen 
percent of patients experienced cough at least once.  Cough occurring one or more times 
was greater in patients receiving propofol with or without other agents (p = .0008), and in 
non-smokers (p = .05).  
 The investigators speculated that coughing was associated with upper endoscopy 
procedures, the use of propofol, longer procedures (unspecified length) (p = .0001), and 
with the development of hiccups (p = .01).  The clinical implication of this being that 
coughing can lead to microaspiration of gastric contents.  Therefore, it is important for 
healthcare providers to exercise constant vigilance for signs of aspiration, especially in 
patients experiencing hiccups, during repositioning (p = .06), and in those undergoing 
“longer” procedures, “deeper” sedation (no p value provided), or both.  Furthermore, this 
study supported a possible association between the dependent variables of oxygen 
desaturation (p = .02) and hypotension (p = .05) in patients who received a deep level of 
sedation (i.e., MOAA/S ≤ 1) during endoscopic procedures, as opposed to lighter levels 
of sedation.  
 Some limitations to this study do exist.  First, the researchers indicate that some 
patients experienced a level of sedation consistent with GA; however, there were no 
criteria for GA provided.  Additionally, sedation was provided by nurses working in 
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conjunction with endoscopists, so the results may not be consistent with those that may 
be obtained from the administration of sedation by certified registered nurse anesthetists 
(CRNA) or anesthesiologists.  Also, a subjective tool (MOAA/S) was used for measuring 
sedation, allowing the potential for some variability in interpretation, and it did not 
include criteria for determining the occurrence of GA.  Lastly, PS classification was not 
included in the presented data.  In conclusion, this study identified the occurrence of deep 
sedation during endoscopic procedures along with some potential risks associated with 
deep sedation during endoscopic procedures. 
 Another prospective, observational study sought to determine if deep sedation 
occurred frequently during elective endoscopy procedures with meperidine and 
midazolam	  (Patel et al., 2005).  A sample size of 80 patients was administered IV 
midazolam (EGD 3.9 mg ± 1.48 mg, colonoscopy 4.38 mg ± 2.13 mg, endoscopic 
retrograde cholangiopancreatography [ERCP] 5.5 mg ± 2.72 mg, EUS 5 mg ± 1.56 mg) 
and meperidine (EGD 77.25 mg ± 22.27 mg, colonoscopy 89.38 mg ± 31.22 mg, ERCP 
103.75 mg ± 31.70 mg, EUS 101.25 mg ± 23.61 mg) for sedation.  All participants were 
over 18 years old, and either PS I or II presenting for EGD (n = 20), colonoscopy (n = 
20), ERCP (n = 20), or EUS (n = 20).  Similar to the previously discussed study (El 
Chafic et al., 2012), the MOAA/S scale was used for measurement of sedation levels.  
However, the investigators modified the scale by assigning deep sedation a value of 1 or 
2 instead of ≤ 1 and eliminating the value of 0.  Initial doses of sedation medications 
(meperidine 50 to 75 mg and midazolam 2 to 3 mg) were at the discretion of the 
endoscopist and administered by a nurse.  Supplementary doses were given in increments 
of 25 to 50 mg of meperidine or 1 to 2 mg of midazolam based on assessments (i.e., signs 
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of discomfort, restlessness, or agitation that were not related to hypoxemia) by the 
endoscopist and nurse.  A single independent physician observed all procedures, 
documented procedural data, and completed MOAA/S assessments.  Recordings of BP, 
HR, SpO2, and MOAA/S score were started with the initial dose of sedation medication 
and repeated every 3 minutes.  Additionally, the time and dose of boluses of sedation 
medication, oxygen desaturation (i.e., < 90%), hypotension (i.e., < 90/50mmHg), the 
need for emergent airway protection or reversal agents, and the lowest intraprocedural 
MOAA/S score were recorded.  Oxygen was administered via NC only when SpO2 
decreased to < 90%, and IV normal saline was given (unspecified dose) for hypotension.  
The endoscopist and registered nurse were blinded to the independent physician’s 
MOAA/S assessments.  
 Results indicated that 68% (54/80) of patients experienced deep sedation, with 
45% (9/20) occurring in colonoscopies, 60% (12/20) in EGDs, 85% (17/20) in ERCPs, 
and 80% (16/20) in EUSs.  This is consistent with the results described in the previous 
study in that 78% (593/757) of patients experienced deep sedation (i.e., MOAA/S ≤ 1) or 
GA (El Chafic et al., 2012).  In the current study, it was also found that transient oxygen 
desaturation (SpO2 < 90%) occurred in 58% (46/80) of patients; however, the existence 
of a correlation with medication doses or times was not indicated, and none resulted in 
severe adverse events, such as	  those	  requiring reversal agents, bag-mask ventilation, or 
intubation.  The procedure type was the only predictor of reaching deep sedation, with 
increased occurrence during more advanced endoscopic procedures (i.e., ERCP and 
EUS).  In conclusion, the investigators found that deep sedation occurs frequently during 
elective endoscopy when meperidine and midazolam are used in an attempt to produce 
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moderate sedation.  Nevertheless, it appears endoscopic procedures may be safely 
performed with analgesia and sedation that reaches a level of deep sedation, as long as 
there is “appropriate monitoring."  Additionally, the authors hypothesized that deep 
sedation and oxygen desaturation might occur more frequently in patients with a higher 
PS status and suggested that future studies include these patients.  
 There were numerous limitations with this study.  Similar to the previous study 
(El Chafic et.al, 2012), the investigators chose to use a subjective tool for measuring 
sedation levels; therefore objective data could not be presented.  This assessment tool did 
not have a value for GA, so it is possible that some patients actually experienced GA but 
it could not be measured.  Another concern was that the researchers stated the 
endoscopist and assistant were blinded to sedation assessments; however, this is not 
possible since they would need to verbally stimulate or physically shake the patients to 
accurately assess their MOAA/S score.  This ultimately could have led to inadequate 
blinding.  In addition, sedation levels and hemodynamic values were only assessed every 
3 minutes; this restricts the ability to determine how long deep sedation occurred, a 
limitation the researchers acknowledged.  Lastly, midazolam and meperidine were chosen 
for sedation.  These are not medications commonly used by anesthesia providers in this 
clinical setting, thus severely impacting the external validity of this research from an 
anesthesia prospective.  Nonetheless, this study validates that deep sedation likely occurs 
with the administration of midazolam and meperidine during endoscopic procedures. 
Endoscopy, Deep Sedation, and Complications 
 Sedation for GI endoscopy has been shown to produce serious complications (57 
out of 388,404 patients), and most are associated with a PS classification of III or greater 
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and emergency procedures (Behrens et al., 2013).  Hypoxia and hypotension are 
particularly common occurrences at deep levels of sedation.  In an assessment of 
complications in patients undergoing GI interventional procedures (N = 100), one study 
found that BIS values < 50 were associated with hypoxia, hypotension, or agitation (p 
values not provided) (Bell et al., 2004).  However, patients with BIS values > 78 did not 
experience hypotension, which shows that deeper levels of sedation can correlate with 
increased adverse events.  This research is discussed more thoroughly later on.  
 In one retrospective study, an “unplanned cardiopulmonary event” was found to 
occur in 3.5 of 1,000 patients undergoing diagnostic colonoscopy (Silvas, Nebel, Rogers, 
Sugawa, & Mandelstam, 1976).  Similarly, another retrospective study established that 
when using midazolam and diazepam for conscious sedation during GI endoscopic 
procedures (N = 21,011), serious cardiorespiratory events accounted for 51.3% of 
complications in 8,919 colonoscopies, and 5.4 out of 1,000 complications overall 
(Arrowsmith et al., 1991).  In both of these studies, serious cardiorespiratory events were 
not specifically defined, the actual depth of sedation was not evaluated, and the specialty 
of the providers administering sedation was not indicated.  
 Additionally, a large national study evaluated the incidence of unplanned 
cardiopulmonary events after GI endoscopy (Sharma et al., 2007).  This was a 
retrospective review of 324,737 endoscopic procedures: 174,255 colonoscopies, 140,692 
EGDs, 6,092 ERCPs, and 3,698 EUSs.  All patients underwent GI endoscopy with 
conscious sedation, but the specialties of the administering persons were not reported.  
There were no exclusions based on demographic data or PS score, however, all patients 
that received sedation with propofol were excluded.  The goal of this study was to 
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determine risk factors that may predict the occurrence of unplanned cardiopulmonary 
events after GI endoscopy.  Data was obtained on GI endoscopies from April 1997 to 
March 2002 and was voluntarily entered in to a database by endoscopists.  Results 
indicate that “unplanned events” were reported in 4,477 (1.4%) of procedures performed 
with conscious sedation, and 3,011 (0.9%) were unplanned cardiopulmonary events (e.g., 
hypoxia, respiratory distress, chest pain, pulmonary edema, arrhythmias, hypotension, 
hypertension).  There were a total of 39 (0.01%) deaths, 28 (0.008%) of which were 
related to cardiopulmonary causes.  Patient age was a significant independent predictor of 
cardiopulmonary unplanned events (p < .001), as well as PS classification, with increased 
incidence associated with higher PS classification: PS I = 0.7%, PS II = 1%, PS III = 
1.8%, PS IV = 3.7%, and PS V = 7.6%.  Additionally, inpatient setting (p < .001), non-
university practice sites (p = .005), the need for reversal medications (p < .001), the use 
of supplemental oxygen (p < .001), and involvement of a trainee (p < .001) were 
significant independent predictors of unplanned cardiopulmonary events as well.  It was 
determined that gender (p = .5) and race (p = .16) were not significantly correlated with 
unplanned cardiopulmonary events. 
 As previously mentioned, endoscopies performed under propofol sedation were 
excluded.  This is a significant limitation to the external validity of the research since 
propofol is commonly used by anesthesia providers for sedation during GI endoscopy 
procedures.  Additionally, all procedures were documented to have been performed under 
conscious sedation.  There was no data provided for establishing the actual sedation level 
of the patients.  Furthermore, the retrospective design of this study limits the internal 
validity.  Lastly, there was no information included about intra-procedure complications.  
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Nevertheless, this study provides data suggesting that complications after endoscopy 
can be related to cardiorespiratory events. 
 One common cardiopulmonary complication that can occur during MAC with IV 
sedation is apnea.  In one randomized controlled trial (N = 39), the incidence was shown 
to be 26% (Soto, Fu, Vila, & Miguel, 2004), and was more common when deeper levels 
of sedation were obtained (Soto et al., 2005).  In a second prospective observational 
study, the investigators used BIS and capnography monitoring to determine if BIS values 
correlated with apnea in 99 patients receiving MAC with IV sedation.  Sedative drugs 
included propofol (n = 84) combined with midazolam (n = 82) and fentanyl (n = 35) 
which were given during orthopedic, vascular, gastroenterology, or “pain” procedures 
(Soto et al., 2005).  Patients received an unspecified combination and dosage of these 
drugs at the discretion of the anesthesia provider – either an anesthesia resident (year of 
residency and total number of providers not reported) or nurse anesthetist under the 
supervision of an anesthesiologist.  The anesthesia provider was blinded to both BIS and 
capnography values, and all patients were administered supplemental oxygen of at least 2 
L/min. Data was collected at “baseline” and every 3 minutes (duration not reported).  The 
investigators notified the anesthesia provider when unnoticed apnea or airway obstruction 
occurred for 60 seconds, as detected by capnography.  
 Statistical analysis of the data showed 49.5% (49/99) of patients experienced at 
least one episode of continuous apnea (i.e., apnea for 60 seconds), none of which were 
identified by the anesthesia provider.  Twenty patients experienced oxygen desaturation 
below 90% at least once, with the lowest SpO2 being 88%, and 17 of these 20 patients 
also experienced apnea.  Patients with apnea had a mean BIS value of 71 ± 14, and those 
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without apnea had a mean BIS value of 83 ± 12, thus the incidence of apnea was 
shown to be greater in patients with lower average BIS values than those with higher 
average BIS values.  Additionally, the mean BIS value in the 3 minutes immediately 
preceding apnea was 55 ± 18, which is largely consistent with GA.  Regression analysis 
showed the likelihood of apnea occurring was 50% when BIS values were approximately 
57, and specific medication combinations did not predict the occurrence of apnea.  There 
were no significant differences in age (51 ± 13), sex, or comorbidities among all 
participants.  Overall, these results demonstrate that lower BIS values correlate with 
increased risk for apnea during MAC with IV sedation. 
 Aspiration can also be a complication of sedation.  From January 2000 to 
November 2009, a population based analysis of all procedural claims for outpatient 
diagnostic colonoscopies in patients who were Medicare beneficiaries, showed an 
increased incidence of aspiration when anesthesia providers were used for the 
administration of sedation (Cooper, Kou, & Rex, 2013).  Since this was a retrospective 
review and Medicare billing codes were used to establish anesthesia involvement, 
demographic data (e.g., type of anesthesia provider and years of experience) was not 
reported.  A total of 165,527 diagnostic colonoscopies in 100,359 patients were analyzed, 
of which 35,128 (21.2%) were anesthesia-assisted and 130,299 (78.7%) were non-
anesthesia-assisted.  A 30-day period of Medicare claims after each diagnostic 
colonoscopy was reviewed for the occurrence of aspiration pneumonia, colonic 
perforation, splenic injury/rupture, or splenectomy.  The overall 30-day mortality was 
similar for colonoscopies assisted by anesthesia (0.32%) versus non-anesthesia (0.28%) 
providers (p = .29).  Aspiration, however, occurred in 173 patients and with more 
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frequency in the anesthesia-assisted group (p = .02).  Splenic perforation occurred in 
101 patients and splenic rupture occurred in 12 patients, but statistically the occurrences 
of these complications (i.e., splenic perforation or rupture) were similar between 
anesthesia-assisted colonoscopies and non-anesthesia-assisted colonoscopies.  
 The increased risk of aspiration pneumonia with anesthesia-assisted 
colonoscopies was thought to be related to the deeper levels of sedation that often occur 
with the use of propofol, which would cause decreased ability of the patient to protect 
their airway.  However, the authors admit this was a non-randomized study and the 
rationale for some patients receiving anesthesia assistance and not others was unknown, 
thus the patients receiving anesthesia-assisted colonoscopies could have had an increased 
number of comorbidities that would also increase their risk for aspiration pneumonia.  
Additionally, anesthesia records were not evaluated, so it was assumed that anesthesia 
providers only used propofol for sedation in the majority of colonoscopy procedures.  
BIS as a Tool for Measuring Sedation 
 The most recent update on the history and current uses of BIS monitoring was 
published in 2006 (Johansen, 2006).  The BIS monitor is essentially a modified EEG that 
can reflect the decreased cerebral metabolic rate caused by anesthetic agents (Kelley, 
2010).  It was first introduced in 1996 to help monitor cortical function during hypnotic 
states and in 2003 it was approved by the Food and Drug Administration (FDA) for 
reducing the incidence of intraoperative awareness (Johansen, 2006; Kelley, 2010).  BIS 
values are measured on a scale of 0 to 100.  A value of 0 indicates complete cortical 
suppression (i.e., an isoelectric EEG signal) and a value of 100 indicates the patient is 
awake (Johansen, 2006; Kelley, 2010).  In actuality, values of 93 or above indicate a state 
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of wakefulness	  (Johansen, 2006).  Sedation is said to occur with BIS values between 
65 and 85, and GA occurs between values of 45 and 60 (Johansen, 2006). 
 BIS does have some limitations.  Elevated electromyographic (EMG) activity 
(i.e., high frequency, low amplitude waves), which occurs from increased muscle tone in 
the forehead or improper electrode placement, may falsely increase BIS values 
(Johansen, 2006).  The signal quality index (SQI) signifies the reliability of the recorded 
BIS value, and should be considered, along with hemodynamics (e.g., BP, HR, RR) and 
visual assessment of the patient, when evaluating depth of sedation (Johansen, 2006; 
Kelley, 2010).  In regards to SQI, a number closer to 100 is more reliable than a number 
closer to 0 (e.g., an SQI value of 97 means that the BIS value is more trustworthy than it 
would be if the SQI value is 34).  Furthermore, BIS values may not be accurate when 
monitored during administration of ketamine (Hans, Dewandre, Brichant, & Bonhomme, 
2005; Roffey, Mikhail, & Thangathurai, 2000) or nitrous oxide (N2O) (Coste, Guignard, 
Menigaux & Chauvin, 2000;	  Ghoneim, 2001).  Additionally, baseline and/or continuous 
values may be altered in patients with dementia	  (Renna, Handy, & Shah, 2003) and those 
with neurological dysfunction such as brain injury or postictal states (Covidien, 2011).  
 Some studies have validated BIS as being “comparable” to other methods of 
assessing sedation level, such as the cerebral state index (CSI) (Cortínez et al., 2007) and 
Ramsay Sedation Score (RSS) (see Appendix C) (Bell et al., 2004).  An overview of 
these studies shows BIS is an accurate tool for monitoring level of sedation.  
 CSI is similar to BIS in that it produces a numerical value that corresponds to 
hypnotic states during anesthesia by integrating EEG signals; also like BIS, awake 
patients have values closer to 100 that progressively decrease as sedation becomes deeper 
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(Anderson & Jakobsson, 2006; Cortínez et al., 2007; Jensen et al., 2006).  The 
mechanisms for producing these values differ; CSI integrates information from EEG 
signals via ratios (i.e., time to frequency) and fuzzy logic (i.e., statements are true, false, 
or on a continuum and based on the logic if X equals Y then Z), whereas BIS uses several 
fragments of an EEG in a mathematical model (i.e., precise calculations) to form a 
numerical value (Cortínez et al., 2007;	  Jensen et al., 2006).  Both have been shown to 
produce a comparable numerical value for similar corresponding clinical states 
(Anderson & Jakobsson, 2006; Cortínez et al., 2007;	  Jensen et al., 2006). 
 One prospective, observational study performed in 2007 compared EEG 
recordings with CSI and BIS over a wide range of sedation levels	  (Cortínez et al., 2007).  
Patients (N =15) were all healthy (i.e., PS I), aged 20 to 40, and all underwent GA for 
surgery.  After entering the operating room, but before any medications were 
administered, baseline CSI and BIS values were recorded for a period of 2 minutes.  Then 
a propofol infusion was started at 300 ml/hr (specific dose not provided) and CSI and BIS 
values were recorded until the burst suppression ratio (BSR) was ≥ 60% in both monitors 
or until MAP was < 50 mmHg.  This allowed for the evaluation of the effect of burst 
suppression activity on both monitors.  Of note, burst suppression is an EEG pattern with 
alternating slow waves of high amplitude (i.e., burst) and flat EEG (i.e., suppression), and 
BSR is the fraction of EEG spent in suppression (Amzica, 2009).  The study protocol 
assessed every 5 seconds after starting the propofol infusion, three clinical end points to 
determine the patient’s level of consciousness.  These included: loss of response to verbal 
command, loss of eyelash reflex, and drop of a weighted syringe from the patient’s hand.  
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Baseline variability, prediction probability, and agreement analysis between indices 
were also evaluated.  
 Statistical analysis showed significance for BIS and CSI correlation with BSR (p 
< .01).  Analysis of the effects of burst suppression on CSI and BIS showed that the CSI 
performance was nearly completely dependent on BSR at all BSR values.  However, BIS 
was not significantly affected until a BSR was ≥ 40% (p values not provided).  The 
overall performance of both monitors were similar, however BIS may have been superior 
for evaluating intermediate anesthetic levels (i.e., values between 60 to 40), whereas CSI 
was better for evaluating deeper anesthetic levels (i.e., values between 40 to 20).  These 
results are consistent with other studies comparing BIS and CSI (Anderson & Jakobsson, 
2006; Jensen et al., 2006) 
 Limitations of this study (Cortínez et al., 2007) included not reporting the type of 
surgery being performed, how GA was maintained (e.g., titration of propofol infusion, 
volatile anesthetic), and EMG activity.  Additionally, there was no correction for possible 
time delays in index calculations (i.e., lag time from actual cortical suppression to visible 
CSI and BIS values).  This is a limitation to the internal validity of this research, but it 
increased the external validity because it evaluated what would be seen in actual clinical 
situations.  
 Another study compared BIS to the subjective RSS (see Appendix C) for 
measurement of conscious sedation in GI interventional procedures such as ERCP, 
percutaneous transhepatic stent insertion, pancreatic pseudocyst drainage, gastrostomy, 
and oesophageal, duodenal, and colonic stents (Bell et al., 2004).  The RSS is a subjective 
assessment tool used to evaluate a patient's level of sedation.  It ranks the patient’s 
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response to either verbal or physical stimuli on a number scale from 1, meaning the 
patient is anxious and agitated or restless or both, to 6, meaning the patient is 
unresponsive to a light glabellar tap (i.e., tap on the forehead between the eyebrows) or 
loud auditory stimulus.  One hundred adult patients with a mean age of 69 years were 
studied. Participants' PS classifications were as follows: 24 PS I, 43 PS II, 25 PS III, 7 PS 
IV, and 1 PS V.  Furthermore, 22 subjects had ischemic heart disease, 10 had diabetes 
mellitus, eight had chronic obstructive pulmonary disease, two were said to be demented, 
and one patient was dysarthric (i.e., had imperfect speech articulation).  
 Patients were divided into two groups with 30 subjects in group A and 70 subjects 
in group B.  Subjects in group A were sedated according to the hospital’s existing 
protocol, which stated that to give safe sedation, the patient must be arousable and able to 
protect their airway.  Consequently, group A patients received baseline sedation 
consisting of 50 mcg of fentanyl and 2 mg of midazolam; furthermore, if after 2 minutes 
sedation wasn’t deemed adequate via a RSS of 3 to 4, another 2 mg of midazolam was 
given.  Midazolam continued to be administered in 2 mg increments every 2 minutes as 
required.  Furthermore, additional doses of fentanyl were given in patients who were 
perceived to be in pain, and doses were halved in patients greater than 80 years old or 
with a PS classification greater than II.  The subjects were assigned a RSS every 5 
minutes with the goal being a RSS of 3 to 4.  BIS values were recorded at 5-minute 
intervals and were blinded to the nurses administering the sedation and the endoscopist or 
surgeon performing the procedure.  
 Group B patients had IV sedation titrated to a predetermined BIS value.  This 
predetermined level was established from the sedation results obtained from group A, 
 
	   46 
where they found that the optimal BIS range for conscious sedation was 80 to 85 
(corresponding to the desired RSS of 3 to 4).  Thus, subjects in group B received the 
same baseline sedative medications as patients in group A.  The only difference in 
regards to the baseline sedation administered was that 2 to 5 minutes were given to allow 
the BIS to return to a constant reading before giving more sedative medications.  If 
needed, 2 mg increments of midazolam were administered at 2-minute intervals to target 
the pre-determined BIS value, and an additional 50 mcg of fentanyl was given for 
perceived pain if it resulted in a sustained increase in BIS for greater than 2 minutes.  If 
giving fentanyl did not return the BIS value to the optimal range desired, more 
midazolam (2 mg) was given until the desired BIS value was achieved.  
 The results of this study demonstrated that only 46.8% of RSS values in group A 
were within the desired RSS of 3 to 4, which in this group correlated to a BIS level of 
87.2 and 80.9.  Based on those results, an optimal BIS range for conscious sedation was 
defined as being between 80 and 85.  Also, a significant negative correlation (i.e., 
correlation between -0.8 and -1.0, demonstrating that as one variable increases the second 
variable decreases to a similar degree) was found when comparing the RSS and BIS 
values between patients (r = -.97, p < .001) and within each patient's values (r = -.90, p < 
.001) in group A.  This significant negative correlation suggested that as the RSS 
increased, BIS values decreased.  Statistical significance in this study was determined by 
p < .05.  Due to the significant negative correlation found between both RSS and BIS in 
group A, the authors concluded that BIS monitoring was an accurate measure of patient 
sedation levels during interventional radiological procedures. 
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 In contrast, Group B’s mean BIS value was 83.79 and this was significantly 
higher (p = .001) than group A’s mean BIS value of 79.77.  Furthermore, 57.5% 
(227/395) of BIS readings in group B were in the optimal BIS range of 80 to 85, 
compared to only 26.5% (48/181) in group A.  These results suggest that using BIS 
values to titrate sedation is more accurate and reliable than the RSS to obtain desired 
sedation levels.  Additionally, group B had no BIS value recorded that was < 60, but this 
occurred 5.5% (10/181) of the time in group A.  
 Other benefits in using the BIS monitor to titrate patients' level of sedation in 
group B included the mean dose of midazolam (4.64 mg) and fentanyl (58.21 mcg) were 
both significantly lower (p = .001 and p = .011, respectively) than group A's mean doses 
of midazolam (6.27 mg) and fentanyl (74.17 mcg).  Likewise, the mean length of the 
procedure and recovery time were found to be significantly reduced with BIS monitoring, 
from 30.3 minutes and 25.10 minutes respectively, to 23.01 minutes and 19.90 minutes in 
group B (p = .018 and p = .001).  
 Besides the above mentioned benefits, the BIS monitor could be useful for 
preventing complications since all patients (unspecified number) sedated to a BIS value < 
50 experienced an unplanned complication such as agitation, hypotension and/or hypoxia.  
Hypotension was defined in this study as SBP < 80 mmHg, and it did not occur in any 
patients with a BIS value > 78.  The only patient who developed hypoxia (i.e., oxygen 
saturation < 92% for > 1 minute) did so with a BIS value of 44.  These results reveal that 
the number of correlated adverse events (e.g., agitation, hypotension, and hypoxia) 
increases with lower BIS values in GI interventional procedures.  Another variable that 
correlated with lower BIS readings was higher patient PS classification (i.e., PS III and 
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IV).  Subjects with a higher PS classification reached deeper levels of sedation, as a 
significant negative correlation was found between the subjects' PS classification and 
their lowest recorded BIS value (r = -.35, p = .01).  
 A limitation of the study included the investigators not mentioning the time the 
BIS value recording started or stopped.  The authors did state, however, that vital signs 
were recorded 5 minutes before the procedure and every 5 minutes during and after the 
procedure until the patient was assessed to have fully recovered from sedation, which was 
defined as being conversant and awake.  Another limitation of this study was that the 
researchers did not operationalize what was meant by a "sustained increase" for BIS.  
Additionally, the study included an inequality in group size with 30 patients being in 
group A and 70 in group B.  There was also noticeable hysteresis between the BIS 
recordings and the patients' sedation levels.  The display of the BIS value was delayed by 
7.5 to 15 seconds from real-time data.  One way the investigators accounted for this 
limitation was by allowing time after the baseline sedative medications were 
administered for a consistent BIS value to appear before giving more sedatives or starting 
the procedure.  By waiting for a consistent value, group B participants had more time for 
the sedative medications to take effect, possibly accounting for the fact that group B 
patients received less medication and recovered significantly faster than group A.  In 
addition, a limitation to the RSS was noted in that the researchers did not operationalize 
"excessive sedation" and whether this could include GA.  Finally, a limitation also 
included that no BIS values < 60 were recorded in group B patients at the 5 minute 
increments; however, BIS values < 60 still occurred in group B patients as demonstrated 
by the BIS ranges given for when complications occurred in each group.  Despite these 
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limitations, the researchers recommended the BIS monitor be used as a standard 
monitoring tool for patients undergoing "routine interventions" since the dosages of 
midazolam and fentanyl, the mean length of the procedure, and the recovery time were all 
significantly reduced with BIS monitoring. 
 Overall, BIS has been shown to be a valid tool for the measurement of depth of 
GA (Cortínez et al., 2007).  In contrast, well-defined BIS values that correlate with 
specific levels of sedation (light, moderate, and deep) remain to be determined.  Less 
clearly defined BIS values that correlate with sedation levels characterized as 
“light/moderate” (Kelley, 2010), “acceptable” (Bell et al., 2004), or the OAA/S scale 
(Liu, Singh, & White, 1997) have been reported in the literature.  For example, an 
OAA/S score of 4 approximates a moderate sedation level and has been shown to 
correlate with a BIS recording of 93 to 95 (Liu et al., 1997).  The use of a BIS monitoring 
system involves minimal risks to the patient and provides anesthesia providers with an 
objective way to estimate the depth of sedation they are providing for their patients, 
especially at deeper sedation levels when it becomes more difficult to clinically assess 
patients (Bell et al., 2004).  However, for multiple reasons BIS monitoring continues not 
to be accepted as a standard of care for anesthesia providers: it is not cost-effective 
(Abenstein, 2009; Liu, 2004), and intraoperative awareness is a rare occurrence (Myles, 
Williams, Hendrata, Anderson & Weeks, 2000; Pollard, Coyle, Gilbert & Beck, 2007; 
Sebel et al., 2004; Shepherd et al., 2013).  Additionally, in one study, authors concluded 
they did not find a reduction in intraoperative awareness by using the BIS monitor 
(Avidan et al., 2008).  Results from this study demonstrated there was no difference in 
the occurrence of intraoperative awareness in patients randomly assigned to BIS-guided 
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anesthesia (i.e., targeting BIS values 40 to 60) and end-tidal anesthetic gas-guided 
anesthesia (i.e., targeting end-tidal anesthetic gas values 0.7 to 1.3 minimum alveolar 
concentration [i.e., the minimum alveolar concentration at which 50% of patients do not 
move in response to skin incision]) (Avidan et al., 2008).  Furthermore, one prospective 
randomized controlled trial used a similar methodology of comparing BIS-guided 
anesthesia to end-tidal anesthetic agent concentration-guided anesthesia to assess patients 
at high risk for awareness.  Criteria to determine high risk for awareness were based on 
previous studies, reviews, and guidelines.  Results indicated that 0.24% (7/2861) of 
patients in the BIS-guided group and 0.07% (2/2852) of patients in the end-tidal 
anesthetic agent concentration-guided group were determined to have definite 
intraoperative awareness, demonstrating no superior use of BIS compared to end-tidal 
anesthetic concentration in preventing intraoperative awareness (p = .98) (Avidan et al., 
2011).  
 In contrast, however, other studies assessing intraoperative awareness using BIS 
monitoring found BIS to be useful (Ekman, Lindholm, Lennmarken, & Sandin, 2004; 
Sebel et al., 2004).  One study concluded that all cases found to have an incidence of 
intraoperative awareness had high BIS values and no cases of awareness were identified 
when BIS values were < 60 (Sebel et al., 2004).  Similarly, another study discovered that 
intraoperative awareness occurred when BIS values were > 60 (Ekman et al., 2004).  
Informed Consent 
 It has been estimated that medications producing sedation and analgesia account 
for 50% or more of complications in endoscopic procedures (Petrini & Egan, 2004) and 
liability may arise from either failure to administer sedation according to the standard of 
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care or failure to obtain proper informed consent (Petrini & Egan, 2004).  In addition, 
providing deeper sedation/analgesia is said to reduce a patient's fear of the procedure and 
allows for a greater recruitment of more at-risk patients; because endoscopists can offer 
"painless" colonoscopy procedures (Petrini & Egan, 2004).  Thus, the proceduralist's 
desire to provide diagnostic care (which includes "deeper sedation/analgesia") that 
generates high patient satisfaction scores, also promotes the undesirable consequences of 
increased procedural risks (Bell et al., 2004; Petrini & Egan, 2004). 
 It is also important to recall that providing deep sedation and/or GA for 
endoscopy procedures are generally not within the scope of practice for non-anesthesia 
providers (CMS, 2011b; Petrini & Egan, 2004; Rex, 2011).  In contrast, the standards of 
practice for GI endoscopists working with a highly trained registered nurse recommend 
sedation levels not exceed a moderate category - which is recognized by the ASGE as 
being usually adequate for routine, uncomplicated GI endoscopy procedures (ASGE, 
Standards of Practice Committee, 2008).  Going beyond a moderate sedation level could 
perhaps result in a violation of the proceduralist's hospital privileges.  It could also 
constitute a violation of the patient's previously agreed upon informed sedation consent.  
 Similarly, anesthesia practitioners are under obligation to deliver anesthesia 
services both they and the patient have agreed upon during the consenting process.  Thus, 
if GA was not part of the agreed upon plan of care, reaching this depth of sedation during 
a colonoscopy procedure could likewise represent a breach in contract of the preoperative 
informed consent (Berg, Appelbaum, Lidz, & Parker, 2001; Bernat & Peterson, 2006). 
 Understandably, accurately obtaining an informed consent is important due to 
differences in risk among the various levels of sedation.  GA carries with it more serious 
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risks than MAC with IV sedation, such as loss of protective airway reflexes (Petrini & 
Egan, 2004), and when looking at all the closed malpractice claims in the ASA's Closed 
Claims Database from 1990 to 2002, only 6% of claims were associated with MAC with 
IV sedation, whereas 78% were associated with GA (Bhanaker et al., 2006).  
 Another issue faced in procedures performed under MAC with IV sedation is 
patients may be given false reassurance by the primary care provider, surgeon, or 
anesthesia provider that they will be completely "asleep" during the procedure and feel no 
discomfort (Feld, 2008).  The anesthesia provider needs to dispel this belief of being 
entirely asleep without the possibility of recall if the procedure is scheduled to be 
performed under MAC with IV sedation.  If the patient is not satisfied with receiving 
MAC (i.e., minimal, moderate, or deep IV sedation) for his or her procedure, then it is 
reasonable to discuss the possibility of consenting for GA instead. 
Summary 
 Colonoscopy is a type of endoscopic procedure that is an effective screening 
option for colorectal cancer (ASGE, 2007).  Sedation during colonoscopies is sometimes 
administered in an office or outpatient setting by nurses under the supervision of an 
endoscopist (Cohen et al., 2006).  However, there has been substantial growth in the 
number of endoscopic procedures performed by anesthesia providers (Liu et al., 2012).  
With nurse-administered sedation, midazolam and fentanyl are often used, but sometimes 
nurses administer propofol (Diprivan) under the direction of a gastroenterologist.  This is 
a controversial practice because patients can unintentionally reach deep levels of sedation 
when propofol is used, including GA.  The 2011(b) recommendations from the ASA 
indicate that any healthcare provider administering propofol for sedation should be 
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trained in providing GA.  Hospira (2009), the manufacturer of propofol, also states that 
only providers trained in GA should administer propofol, but additionally, that person 
should not be involved in the conduction of the procedure.  A 2006 nationwide survey 
found that endoscopists were more satisfied with sedation from propofol rather than 
sedation with a benzodiazepine combined with a narcotic because propofol allowed for 
better sedation, superior analgesia, reduced recovery time, faster return to usual activity, 
and improved quality of endoscopic examination (Cohen et al., 2006).  
 Levels of sedation can be viewed as a continuum, with minimal sedation 
(anxiolysis) being the lightest level, and GA (i.e., patient is not arousable, independent 
ventilation is usually impaired, airway assistance is often needed, positive pressure 
ventilation may be necessary, and cardiovascular function may be compromised) being 
the deepest (ASA, 2009).  Furthermore, the ASA (2013) identified MAC as including 
varying levels of sedation, but if the patient becomes unconscious and the ability to 
respond purposefully is lost, GA has consequently occurred, regardless of the need for 
airway instrumentation.  Moderate sedation (i.e., patients respond purposefully to verbal 
command, maintain patent airways without intervention, sustain adequate spontaneous 
ventilation, and usually maintain cardiovascular function) is usually considered adequate 
for routine, uncomplicated GI endoscopy procedures, but maximizing patient comfort 
while minimizing risk during GI endoscopy should be the clinical goal (ASGE, Standards 
of Practice Committee, 2008). 
The BIS monitor is a modified EEG that can reflect the decreased cerebral 
metabolic rate caused by anesthetic agents (Kelley, 2010).  BIS has been validated as 
being comparable to other methods of assessing sedation level, such as the CSI and RSS, 
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and has been shown to be a useful tool for the measurement of “different” levels of 
sedation to help guide titration of sedative medications (Bell et al., 2004; Cortínez et al., 
2007; Hata et al., 2009).  To date, although some studies have used BIS monitoring to 
titrate or assess a patient's sedation level during “MAC anesthetics with IV sedation” 
(Bang et al., 2013; Hata et al., 2009) or “conscious sedation” (Drake et al., 2006), there 
has been no research that has quantified sedation levels (i.e., mild, moderate, deep, and 
GA) via the BIS monitor in patients undergoing MAC with IV sedation during elective 
colonoscopies. 
 BIS values ≤ 60 correlate with a state of GA (Bell et al., 2004; Cortínez et al., 
2007; Drake et al., 2006; Hata et al., 2009; Johansen, 2006; Kelley, 2010).  A study from 
2010 concluded that GA, as measured by BIS monitoring, occurs frequently in elderly 
patients undergoing spinal anesthesia combined with propofol sedation, and titrating 
propofol to a pre-determined BIS value range decreases that occurrence (Sieber et al., 
2010).  Additionally, evidence has suggested that a greater number of adverse events may 
occur in patients undergoing endoscopic submucosal dissection procedures when BIS 
values are maintained between 56 and 65 (Hata et al., 2009).  These deep levels of 
sedation during endoscopy can have adverse effects, such as aspiration, hypoxia, 
hypotension, and agitation (Bell et al., 2004; El Chafic et al., 2012; Soto et al., 2005).  
One study found that during GI interventional procedures, BIS values < 50 were 
associated with more adverse events and no patients experienced hypotension with a BIS 
value > 78 (Bell et al., 2004).  Furthermore, apnea is a complication that can occur with 
MAC with IV sedation.  One study showed the incidence to be 26% (Soto et al., 2004).  
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 There has been significant growth in anesthesia providers administering 
sedation for endoscopic procedures (Liu et al., 2012).  Due to this growth and the 
potential for the occurrence of unintended GA (El Chafic et al., 2012), it is important to 
assess the current sedation practices administered by anesthesia personnel and non-
anesthesia healthcare providers for these procedures.  In addition, it is imperative to 
determine whether a change in practice (e.g., selection of sedation medications, personnel 
administering sedation, type of consent) would be beneficial.  The BIS monitor has been 
demonstrated as an additional way to help assess whether patients undergoing surgical 
and/or diagnostic procedures are experiencing GA (Bell et al., 2004; Cortínez et al., 
2007; Hata et al., 2009).  Being able to assess GA levels of sedation is essential for 
patient safety, given GA carries more risk for ventilatory and circulatory complications 
(e.g., aspiration, respiratory arrest) than minimal, moderate, or deep IV sedation (Petrini 
& Egan, 2004).  Therefore, if levels of GA are being reached in endoscopic procedures 
such as colonoscopies, patients should be accurately informed of this possibility and 
consented for GA. 
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CHAPTER THREE:  METHODOLOGY 
 
 
Research Design 
 
This study incorporated a non-experimental prospective observational research 
design, with a convenience sampling of PS I, II, and III patients undergoing sedation for 
elective colonoscopies.  This research design allowed surveillance of real-world 
conditions that may actually be encountered in clinical settings, and it enabled the 
researchers to have limited or no influence on the actions of the anesthesia providers or 
participants in the study. 
Setting 
Data was collected by researchers over a four-week period at a non-teaching rural 
hospital in Western North Carolina.  All procedures were carried out in an endoscopy 
suite, and sedation was provided by either an anesthesiologist (N = 1) or a CRNA (N = 
11).  A limitation with using only one facility is the possibility that sedation could be 
carried out differently at other institutions due to variations in site-specific protocols, 
skills of gastroenterologists, and expectations of patients. 
Population and Sample 
There were a total of 41 subjects enrolled in the study with a range of PS 
classifications between I to III.  Two patients were excluded from the study because of 
documented neurological deficits secondary to residual effects from a CVA.  Other 
exclusion criteria included patients undergoing sedation in which the anesthesia provider 
used ketamine or N2O.  Because this was a convenience sampling of patients having 
elective colonoscopies over a four-week period, the sample size could not be pre-
determined.  
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Protection of Human Subjects 
Before commencement of data collection, approval for this study was obtained 
from the institutional review board (IRB) of the participating hospital on March 18, 2013 
(see Appendix D).  This study was also approved by Western Carolina University’s IRB 
on April 11, 2013, with the IRB approval number 2013-0246 (see Appendix E).  To 
attenuate bias and assure confidentiality of all study participants, identification numbers 
were assigned to each patient and anesthesia provider.  These identification numbers 
allowed avoidance of using any patient or provider identifiers such as name and/or 
medical record number.  No participation risks were identified for this observational 
study. 
In the preoperative holding area on the day of their scheduled procedure, the 
researchers met with all patients undergoing elective colonoscopies.  The purpose of the 
study, the participant’s role, confidentiality, and right to refuse were explained to each 
patient.  As part of the consenting process, contact information for the primary 
investigators, Western Carolina University’s IRB, and the participating hospital's IRB 
were provided to all subjects (see Appendix F).  At that time, all patients who met the 
enrollment criteria were invited to participate in the study.  Additionally, each anesthesia 
provider was informed about the purpose of the study, their right to refuse, and 
confidentiality measures (see Appendix G).  Contact information for the primary 
investigators, Western Carolina University’s IRB, and the participating hospital's IRB 
were also shared with the anesthesia providers.   
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Instruments 
The BIS monitor is a modified EEG.  It was first introduced in 1996 to help 
monitor cortical function during hypnotic states, and in 2003 it was approved by the FDA 
for reducing the incidence of intraoperative awareness (Johansen, 2006; Kelley, 2010).  
BIS values are measured on a scale of 0 to 100 (Kelley, 2010).  A value of 0 indicates 
complete cortical suppression, and values of 93 or above indicate a state of wakefulness 
(Kelley, 2010).  Moderate sedation occurs at BIS values between 65 and 85, and GA is 
said to occur between values of 45 and 60 (Kelley, 2010).  Some studies have shown an 
increased number of adverse events such as hypotension and hypoxia with BIS values < 
60 (Arrowsmith et al., 1991; Charlton, 1995).  Other studies have shown that a BIS value 
of 80 correlates with what has been described as an “ideal” level of sedation for 
colonoscopies (Bell et al., 2004; Bower et al., 2000). 
The BIS monitor is the most extensively researched EEG device currently used to 
evaluate depth of anesthesia during surgical procedures, and it is frequently used as a 
monitor in the operating room to measure the depth of anesthesia and to help guide the 
titration of medications during GA (Bruhn et al., 2003; Cortínez et al., 2007; Doufas et 
al., 2003; Ge et al., 2002; Kearse et al., 1998).  BIS measurements have also been shown 
to be useful with measuring sedation levels during endoscopic procedures when sedation 
is administered by anesthesia (e.g., CRNAs, anesthesiologists) and non-anesthesia (e.g., 
registered nurses) providers (Bell, et al., 2004; Hata et al., 2009; Leslie et al., 2002; 
Siddiqui et al., 2012).  Additionally, there have been some studies that have looked at the 
use of BIS as an adjunctive monitor in titrating a patient’s sedation level through the use 
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of various drugs, such as propofol, fentanyl, and midazolam (Bell et al., 2004; Drake et 
al., 2006; Hata et al., 2009).  
The BIS A-2000™ monitor was used to monitor the depth of sedation and 
possible correlated adverse events during colonoscopies.  As part of the study design, 
interventions were not implemented in response to observed BIS values, and notification 
to providers was not given when BIS values dropped below 60 (indicating GA had 
occurred).  
Data Collection and Field Procedures 
Participation in the study began from the time consent was obtained in the 
preoperative holding area to the time the patients' first set of vital signs were taken in 
PACU.  In the preoperative area, per instructions presented on the BIS sensor packaging, 
the forehead was cleaned with an alcohol wipe and then dried with gauze.  The strip was 
then applied in a diagonal direction starting with sensor number 1 about 2 inches above 
the bridge of the nose, followed by sensor number 4 directly above the eyebrow and 
ending with sensor number 3 on the temple, between the corner of the eye and the 
hairline.  The edges of each sensor were pressed, and then the center of each sensor was 
firmly pressed for about 5 seconds.  The sensor strip was then connected to the BIS A-
2000™ monitoring device and the first BIS value was recorded.  At this time, a non-
invasive BP cuff was placed on the patient's arm and the first set of vital signs, including 
HR, SpO2, RR, SBP, DBP, MAP, temperature, and liters of oxygen flow were 
documented.  
After arriving in the endoscopy suite (procedure room), a second set of BP 
measurements (SBP, DBP, MAP) were taken, followed immediately with a recording of 
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HR, SpO2, RR, and BIS value.  A stopwatch was also started just after the BP 
measurement was taken to help maintain accuracy for data-recording intervals in the 
endoscopy suite.  Recording of the presence or absence of ETCO2 (measured via the 
Salter Labs 4707F adult Salter NC) and liters of oxygen flow began as soon as the NC 
was placed on the patient in the procedure room.  BIS values and ETCO2 values then 
continued to be recorded every minute throughout the remainder of the procedure.  Also 
during this time, SBP, DBP, MAP, and HR via ECG (lead chosen by provider) were 
recorded every 5 minutes, and any intraoperative changes in liters of oxygen flow from 
baseline oxygen flow rates were documented at the actual time they occurred.  
Additionally, the SpO2 value was noted every 5 minutes, except when it dropped below 
95%.  If this occurred, recording of data took place at 1-minute intervals until the SpO2 
returned to 95% or greater, when it was again recorded at 5-minute intervals.  Without 
regard to frequency, the lowest BIS value observed during each procedure was noted.  
Also, temperature recordings were taken only in the preoperative area and in the PACU. 
All data was recorded and documented by one of the investigators until the patient 
was detached from monitors in the procedure room in preparation for transfer to PACU.  
Additionally, medications administered and documented by the anesthesia provider 
during the procedure were recorded retrospectively, and included the dosage of 
medications and time administered.  The form of primary medication delivery (i.e., one 
time/single bolus followed by infusion, intermittent bolus, infusion, or combination of 
intermittent bolus and infusion) was also observed and documented by one of the primary 
investigators.  
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Likewise, airway assistance maneuvers and oxygen delivery devices used by 
the anesthesia provider were recorded throughout the procedure.  This included, but was 
not limited to, chin lift, jaw thrust, combination of chin lift and jaw thrust, and placement 
of nasopharyngeal airway, oropharyngeal airway, NC, face mask, non-rebreather mask, 
bag mask, LMA and endotracheal tube.  Upon arrival to PACU, one set of vital signs 
including SBP, DBP, MAP, HR, SpO2, temperature, and RR were recorded.  
Additionally, the time of arrival in the PACU, oxygen delivery method and liter flow, and 
one final BIS value were noted.  
Chart documents relevant to the anesthesia care received throughout the 
procedure were collected.  This included copies of the anesthesia record, and information 
from the pre-anesthesia assessment sheet, PACU record, anesthesia and/or surgical 
consent form, and surgeon’s history and physical and/or medication list.  Total drug 
dosages, length of procedure, consented anesthetic plan (e.g., GA, MAC with IV 
sedation), postoperative diagnosis, and the patient’s demographic data (i.e., gender, age, 
body mass index (BMI), weight, height, and PS) were recorded.  Additional information 
obtained retrospectively from chart review included use of oxygen at home, presence of 
obstructive sleep apnea and use of a home continuous positive airway pressure (CPAP) or 
bi-level positive airway pressure (BiPAP) device, history of previous airway surgeries, 
and major comorbidities.  Lastly, the BIS monitor used in the endoscopy suite was placed 
out of immediate view from the anesthesia providers and the gastroenterologists or 
surgeons performing the colonoscopy, which facilitated the blinding of healthcare 
providers to BIS values obtained during the procedure.  The healthcare providers were 
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also reminded of the need to shield their face from the BIS values during the 
endoscopy procedure. 
A survey tool (see Appendix H) was used to collect demographic data on 
anesthesia providers.  This included 1) the year the CRNA or anesthesiologist passed 
their national certification exam, 2) the number of years or months of experience with 
providing anesthesia care for patients scheduled for colonoscopies, 3) the opinion of the 
anesthesia provider of the level of sedation they typically provide during colonoscopies 
(i.e., MAC, GA or both), and 4) the highest educational degree obtained (i.e., Doctorate, 
Masters, Bachelors, or Diploma). 
Data Analysis 
 All quantitative and numerically-coded demographic data was entered into an 
Excel spreadsheet before analysis.  A statistician was consulted to assure the accuracy of 
proposed statistical tests and provide guidance to investigators on the use of additional 
statistical tests deemed essential for the study.  Correlation analysis (r and r2) was used 
for continuous data (e.g., length of procedure, age, BMI, years as provider, propofol 
dose/min).  The Mann-Whitney U test compares two groups with ordinal data, and was 
used for analysis of correlation between SpO2, ETCO2, and gender.  One-way ANOVA is 
a parametric test used for comparing the means of three or more groups (e.g., BIS values 
of ≤ 60, ≤ 40, and ≤ 20) and was chosen for analyzing BIS values versus experience of 
the anesthesia provider with colonoscopies (e.g., 1-2 years, 3-5 years, 6-10 years).  The 
Kruskall-Wallis, which is an extension of the Mann-Whitney U test and incorporates 
ordinal data for three or more groups, was utilized to determine if a correlation existed 
between BIS values, PS classification, SpO2, ETCO2, education, and length of experience 
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as an anesthesia provider.  An unpaired t-test, which compares two or more 
independent samples, was used to assess potential relationships between gender and BIS 
values.  Simple quantitative statistics were used to calculate all other data. 
Limitations 
 The BIS monitor was secured on a pole attached to the head of the bed, so 
inadequate blinding of anesthesia providers to BIS values may have inadvertently 
occurred.  Instructions were provided to anesthesia personnel to avoid titrating sedation 
medication based on BIS values accidentally observed; however, it was possible that 
titration did occur and statistical analysis could not account for this possibility.  Another 
limitation of the study was the duration of apnea (i.e., absence of ETCO2) was only 
measured at 1-minute intervals.  For example, if a patient experienced 1.25 minutes of 
apnea, it would have been recorded as a duration of 1 minute; in contrast, if a patient 
experienced 35 seconds of apnea it may not have been recorded at all due to the 
previously mentioned assessment intervals of 1-minute.  Additionally, negative ETCO2 
waveforms obtained via Salter NC’s can be the result of situations other than apnea, such 
as a patient breathing out of their mouth instead of their nose.  Furthermore, some 
providers performed a chin lift in the absence of apnea, most likely as a preventative 
measure.  Since apnea may have occurred in the absence of this prophylactic chin lift, 
measuring the actual frequency of apnea, along with resulting interventions during 
colonoscopies, was not possible.  This inability to precisely record the frequency and 
interventions related to apnea was a limitation that likely skewed statistical analysis 
involving airway maneuvers in correlation with BIS values, and the presence or absence 
of ETCO2.   
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 Two other limitations of the study involved 1) the anesthesia providers' 
assignment of a PS classification to each patient, and 2) the absence of SQI and EMG 
values with the BIS A-2000™.  The former could have hindered analysis of the lowest 
BIS value obtained during each colonoscopy procedure relative to recorded PS 
classification.  The reason this represents a limitation is the subjectivity involved with PS 
assignment; it is possible the recorded PS value was inaccurate for some patients in the 
study.  Regarding the BIS A-2000™ monitor, it allows for visualization of a non-
numerical scale (see Figure 1) of real-time SQI and EMG data, but does not provide a 
numerical value that can be recorded for statistical analysis in correlation with BIS 
values.  One final limitation was that all subjects were consented for IV GA for their 
elective endoscopy procedure; thus, it would be anticipated that anesthesia providers 
would only unexpectedly deliver a lighter level of sedation during the colonoscopy 
procedure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Photograph of BIS A-2000TM monitor displaying SQI and EMG non-numerical  
data. BIS = bispectral index; SQI = signal quality index; EMG = electromyography; EEG =  
electroencephalogram. 
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CHAPTER FOUR:  RESULTS  
 
 
Sample Characteristics 
 Forty-one adult patients undergoing elective, colonoscopy procedures were 
observed at one hospital.  Two patients were excluded due to a history of a CVA with 
current neurological deficits (N = 39).  Descriptive statistics were used to analyze 
participant demographics, which included clinical characteristics (see Table 2).  Twenty-
one of the subjects were male (53.8%) and 18 were female (46.2%).  Additionally, 5.1% 
(2/39) of study participants were PS I, 53.8% (21/39) were PS II, and 41.0% (16/39) were 
PS III.  After assessing patient's smoking history, 20.5% (8/39) were found to be current 
smokers.  No patients were documented as using oxygen at home and none had 
obstructive sleep apnea.  
Table 2 
 
Patient and Clinical Characteristics 
     
Variable  Mean  Range   
Age (years)    64.8    30-90  
BMI (kg/m2)    27.3              15.1-40.4 
Weight (kg)    81.2              38.6-124.7 
Propofol dose (mg)              315.0            140.0-650.0 
Propofol dose/kg (mg)     4.1   1.9-9.6 
Propofol dose/minute (mg)  20.4   9.4-50.0 
Length of procedure (minutes)      17.3   8.0-39.0 
BISa      47.6      5-98 
Lowest BIS    28.6      3-53 
Minutes BIS ≤ 60   13.1      1-34 
Minutes BIS ≤ 40     5.8      0-31 
Minutes BIS ≤ 20     0.5      0-7 
Minutes SpO2 ≤ 90     0.3      0-3 
________________________________________________________________________________________________ 
Note. N = 39. BMI = body mass index; BIS = bispectral index.  
aBIS mean and range values are derived from BIS recordings taken after sedation was initiated in the endoscopy suite until the end of 
the procedure. 
 
 Preoperatively, all patients had a baseline BIS measurement between 97-98 and 
every patient experienced a BIS measurement ≤ 60 (i.e., GA) at least once during their 
procedure.  The lowest recorded BIS value in one subject was 3 and there were three 
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separate episodes recorded for this patient of an absent ETCO2 waveform.  The first 
episode occurred after the initial propofol bolus and was accompanied by a decline in 
oxygen saturation to 84%, which resolved with a chin lift.  The other two episodes 
resulted in a negligible drop in oxygen saturation to 97% and 98%.  Overall, out of a total 
of 656 minutes of recorded data for 39 patients, 51 minutes of absent ETCO2 (7.9%) were 
found (see Figure 2).  All patients received oxygen via NC at flows 2-5 L/min and there 
were a total of seven patients (17.9%) whose oxygen saturation dropped to ≤ 90% for at 
least 1 minute.  One anesthesia provider failed to monitor ETCO2; therefore, ETCO2 data 
on three patients under their care could not be obtained.  
 
  
 
 
 
 
 
Figure 2. Bar graph demonstrating the number of minutes of absent ETCO2 each patient experienced. Patients 2, 3, and  
10 did not have ETCO2 monitored by the anesthesia provider. ETCO2 = end tidal carbon dioxide. 
 
 The average propofol dose administered per patient during the entire colonoscopy 
procedure was 315 mg and 4.1 mg/kg respectively.  Propofol was administered via 
intermittent boluses in 94.9% (37/39) of patients and by bolus followed with infusion in 
5.1% (2/39) of patients.  In addition, no patient received fentanyl or midazolam.  In 
89.7% of patients (35/39) MAP decreased at the first BP measurement after the initial 
propofol bolus, of which 61.5% (24/39) of subjects had a 10.1-42.4% MAP decrease at 
this time (see Figure 3), and in more than half of these 24 participants (54.2%), the MAP 
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decreased by 21.5-42.4% (see Figure 4).  Overall, the greatest MAP decrease found 
was 50.8% and this occurred in one patient 7 minutes after the end of the procedure.  In 
contrast, 10.3% of patients (4/39) had an increase in MAP at the first BP measurement 
after the initial propofol bolus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Bar graph demonstrating the percentage of patients with a MAP decrease < 10.1% or  
10.1-42.4% at the first BP measurement taken after the initial propofol bolus. There were no  
patients with a MAP decrease > 42.4% at this measurement time. N = 39. MAP = mean arterial  
pressure; BP = blood pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Bar graph exhibiting further breakdown of MAP decrease at the first BP measurement 
after the initial propofol bolus in the 61.5% of patients (24/39) who had a MAP decrease from  
10.1-42.4%. MAP decreases of 10.1-19.0% and 21.5-42.4% shown. N = 24. MAP = mean  
arterial pressure; BP = blood pressure. 
 
 A total of 12 anesthesia providers were surveyed with a 100% response rate (see 
Table 3).  The average number of years as an anesthesia provider was 14.3, and 41.7% 
(5/12) of the respondents had > 10 years of experience with providing anesthesia for 
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colonoscopies, 33.3% (4/12) had 6-10 years of experience with colonoscopies and 
8.3% (1/12) had 3-5 years of experience with colonoscopies.  Only 16.7% (2/12) had 0-2 
years of experience with colonoscopies.  Additionally, 8.3% (1/12) of anesthesia 
professionals' highest level of education was a doctorate, 66.7% (8/12) a master's degree, 
8.3% (1/12) a bachelor's, and 16.7% (2/12) a diploma.  When asked what percentage of 
colonoscopies they believed they were delivering a MAC anesthetic, GA, or a 
combination of both, 50% (6/12) of the respondents believed they were administering GA 
100% of the time, whereas just one anesthesia provider believed they were delivering 
MAC 100% of the time.  The remaining anesthesia professionals (5/12) believed they 
were administering a combination of a MAC anesthetic and GA (See Figure 5).  Survey 
responses were likely influenced by the fact that all patients undergoing elective 
colonoscopies at this hospital were consented for IV GA.  
Table 3 
 
Anesthesia Provider (AP) Survey Responses  
 
AP No. of 
years as 
an AP 
AP's years of 
experience 
with 
colonoscopies 
Highest 
degree held 
% of 
Colonoscopies 
believe providing 
MAC 
% of 
Colonoscopies 
believe  
providing GA 
% of 
Colonoscopies 
believe 
providing 
combinationc  
No. of 
patients 
cared for 
by APd 
  1    29          > 10   Diploma      0             100             0       2 
  2a      4          6-10  Doctorate      3               97             0       4 
  3      9          6-10  Master's           0                 0                   100      1 
  4b    12          > 10  Master's  100                 0             0     14 
  5      8          6-10  Master's           0             100             0       1 
  6      1           0-2  Master's           0             100                       0      1 
  7     28          > 10  Master's       99                 1             0       1 
  8     29          > 10  Bachelor's      0             100             0       4 
  9       4           3-5  Master's           0             100             0       2 
10       1           0-2  Master's           0                 0                   100      6 
11       8          6-10  Master's           0             100             0       2 
12     38          > 10  Diploma    90               10                       0      2 
______________________________________________________________________________________ 
Note. AP = anesthesia provider; MAC = monitored anesthesia care; GA = general anesthesia. 
aAnesthesiologist. bOnly AP who believed they were administering MAC 100% of the time for colonoscopies. cGA and MAC. 
dDemographic data not included as part of the survey. 
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Figure 5. Pie graph with survey results of the percentage of anesthesia  
providers who believed they were delivering a level of sedation consistent 
with MAC 100% of the time, GA 100% of the time, or a combination of   
MAC and GA during colonoscopy procedures. N = 12. GA = general  
anesthesia; MAC = monitored anesthesia care. 
 
Major Findings 
 The quantitative data were analyzed using Prism 6.0c software.  Alpha was two-
tailed and set at .05 for all tests, and Pearson product-moment correlation coefficient 
(Pearson r) test was used to assess whether an association existed between each patient's 
BIS measurements and 1) their respective demographics, 2) clinical characteristics for 
each subject (e.g., length of procedure, propofol dose given per minute), and 3) each 
participant's anesthesia provider.  Furthermore, r values provide an estimate of how much 
one variable accurately predicts another (Hatcher, 2003).  A value of zero means there is 
no relationship between the two variables.  Values ranging from ±0.2-0.4 represent a mild 
or weak association between variables, ±0.5-0.7 a moderate association, and ±0.8-1.0 a 
strong association.  An r value of 1.0 represents a perfect positive correlation (e.g., the 
longer the length of the procedure, the more minutes patients spent with BIS values ≤ 60) 
and -1.0 represents a perfect negative correlation (e.g., the longer the length of the 
procedure, the less minutes the patients spent with BIS values ≤ 60) (Hatcher, 2003).  
50% 
42% 
8% 
Believe Delivering GA 100% of the Time 
Believe Delivering a Combination of MAC and GA 
Believe Delivering MAC 100% of the Time 
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 In addition, the coefficient of determination (r2) was computed.  These values 
are a measure of the proportion of variance in one variable that can be explained by its 
relationship to (or accounted for by) a second variable.  The calculated values range from 
0 (0%) to 1 (100%).  For example, a value of 1.0 means 100% of the deviation in one 
variable is correlated with the variance in the second variable (Hatcher, 2003).  A value 
of 0.0 means knowing one variable does not help to predict the other.  In essence, the 
higher the number, the better the ability to determine how much divergence of one 
variable is due to (or can be explained by) another variable's variability (Hatcher, 2003).  
 Every patient experienced BIS values ≤ 60 for at least 1 minute or more (range of 
1-34 minutes or 11.1-100% of their length of procedure); 76.9% of subjects were 
recorded as having a BIS value ≤ 40 for 1-31 minutes or for 4.5-100% of their procedure, 
and 15.4% of participants experienced a BIS value ≤ 20 for 1-7 minutes or for 4.0-33.3% 
of their procedure.  A strong positive correlation was found between the length of the 
procedure and the number of minutes patients had a BIS recording ≤ 60 (r = .85, r2 = .72, 
p < .001) (see Table 4).  This suggests the longer the length of the procedure, the greater 
the number of minutes patients experienced BIS values ≤ 60 (See Figure 6).  
Additionally, a weaker but still significant correlation was found when comparing the 
length of the procedure and the number of minutes patients were reported to have BIS 
values ≤ 40 (r = .43, r2 = .18, p = .007) (see Figure 7).  The significance demonstrated 
between these two variables is an important finding regardless of the weaker correlation; 
it suggests there is a low risk that chance alone accounted for the mild positive 
correlation, which implies as one variable increases, the other also slightly increases.  
Conversely, the correlation for the length of the procedure and the number of minutes 
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patients experienced BIS values ≤ 20 was not found to be significant (r = .31, r2 = .10, 
p = .052) (see Figure 8). 
Table 4 
 
Summary of Length of Procedure Correlations 
 
Correlation Length of 
procedure 
versus 
lowest BIS 
Length of 
procedure 
versus 
minutes BIS 
≤ 60 
Length of 
procedure 
versus  
minutes  
BIS ≤ 40 
Length of 
procedure 
versus 
minutes BIS 
≤ 20 
Length of 
procedure 
versus 
minutes  
SpO2 ≤ 90 
Length of 
procedure 
versus 
minutes of 
absent 
ETCO2a 
      r                -.24              .85                   .42              .31               -.14              .52                    
                                      
      r2                 .06                 .72                   .18                  .10                 .02                 .27      
                 
      p                 .137        <.001*               .007*              .052               .409              .001* 
______________________________________________________________________________ 
Note. BIS = bispectral index; SpO2 = saturation of peripheral oxygen; ETCO2 = end tidal carbon dioxide 
aOnly 36 subjects were used to calculate all correlation and p values for absent ETCO2 due to no ETCO2 monitoring by  
one anesthesia provider in three patients. 
*p < .05 
 
 
 
 
 
 
 
 
Figure 6. Correlation graph demonstrating the relationship found between the length of the  
procedure and the number of minutes the patient experienced BIS values ≤ 60. r = .85. r2 = 
.72. p < .001. BIS = bispectral index.  
*p < .05 
 
 A significant, moderate correlation was found when the length of the procedure 
was compared to the number of minutes patients had an absent ETCO2 waveform (r = 
.52, r2 = .27, p = .001) (see Figure 9).  This moderate correlation suggests the longer the 
procedure, the more minutes patients were likely to experience an absent ETCO2 
waveform.  There were no strong or moderate correlations or significance found between  
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Figure 7. Correlation graph demonstrating the relationship found between the length of the  
procedure and the number of minutes the patient experienced BIS values ≤ 40. r = .43. r2 = .18. 
p = .007. BIS = bispectral index.  
*p < .05 
 
 
 
 
 
 
 
 
 
  
 
Figure 8. Correlation graph demonstrating the relationship found between the length of the  
procedure and the number of minutes the patient experienced BIS values ≤ 20. r = .31. r2 = .10. 
p = .052. BIS = bispectral index.  
*p < .05 
 
the length of the procedure and the number of minutes patients had a SpO2 ≤ 90 or the 
patient's lowest BIS value obtained during the procedure (see Figures 10 and 11). 
 Another significant, mild correlation was found when comparing the number of 
minutes patients had an absent ETCO2 waveform with the number of minutes patients 
experienced GA (i.e., BIS values ≤ 60) (r = .49, r2 = .24, p = .002).  This r value suggests 
the greater number of minutes patients experienced an absent ETCO2 waveform, the 
more minutes patients had BIS values ≤ 60, implying that IV GA has an association with  
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Figure 9. Correlation graph demonstrating the relationship found between the length of the  
procedure and the number of minutes the patient experienced an absence of ETCO2. r = .52. r2  
= .27. p = .001. ETCO2 = end tidal carbon dioxide. 
*p < .05 
 
 
 
  
 
 
 
 
 
 
 
Figure 10. Correlation graph demonstrating the relationship found between the length of the  
procedure and the number of minutes the patient experienced a SpO2 ≤ 90. r = -.14. r2 = .02. p  
= .409. SpO2 = saturation of peripheral oxygen. 
*p < .05 
 
adverse perioperative events in patients who undergo elective colonoscopies (see Figure 
12).  Also, after comparing the number of minutes patients had a SpO2 ≤ 90% to the 
number of minutes patients experienced GA (i.e., BIS values ≤ 60), no significance or 
mild, moderate, or strong correlations were found (r = -.17, r2 = .03, p = .299) (see Figure 
13).  Overall, the adverse event of an absent ETCO2 waveform (i.e., apnea) was shown to 
have a significant correlation with IV GA, but there was no significant correlation shown 
when comparing the number of minutes patients had a SpO2 ≤ 90% (i.e., desaturation) to  
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Figure 11. Correlation graph demonstrating the relationship found between the length of the  
procedure and the patient's lowest BIS value observed throughout the procedure. r = -.24. r2 =  
.06. p = .137. BIS = bispectral index. 
*p < .05 
	  
IV GA.  In addition, apnea and desaturation did not result in any apparent clinically 
significant events and no patients required airway interventions, such as placement of a 
nasopharyngeal airway, oropharyngeal airway, face mask, non-rebreather mask, bag 
mask, LMA, or endotracheal tube. 
 
 
 
  
 
 
 
 
 
 
Figure 12. Correlation graph demonstrating the relationship found between the number of  
minutes the patient experienced an absent ETCO2 waveform and BIS values ≤ 60. r = .49. r2 =  
.24. p = .002. BIS = bispectral index; ETCO2 = end tidal carbon dioxide. 
*p < .05 
 
 Furthermore, a moderate positive correlation and significance (r = .54, r2 = .29, p 
< .001) was demonstrated when comparing BMI with the patients' lowest BIS value 
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Figure 13. Correlation graph demonstrating the relationship found between the number of  
minutes the patient experienced a SpO2 ≤ 90 and BIS values ≤ 60. r = -.17. r2 = .03. p = .299.  
BIS = bispectral index; SpO2 = saturation of peripheral oxygen. 
*p < .05 
 
obtained throughout the entire procedure.  This suggested that patients with a larger BMI 
(compared to patients with lower BMIs) were more likely to have the greatest nadir in 
recorded BIS value (see Figure 14).  Additionally, significance was demonstrated when 
BMI was compared to the number of minutes patients had a BIS value ≤ 60 (r = -.42, r2 = 
.17, p = .008) and ≤ 40 (r = -.51, r2 = .26, p < .001).  The r values suggest the greater the 
BMI, the fewer number of minutes patients experienced BIS values ≤ 60 and ≤ 40 (see 
Figures 15 and 16).  No significance or strong or moderate correlations were 
demonstrated when comparing BMI to the number of minutes patients had BIS values ≤ 
20, SpO2 ≤ 90, or an absent ETCO2 waveform (see Table 5).  Similarly, no strong 
correlations, moderate correlations, or significance were found when the patients' ages 
and the survey respondents' number of years as an anesthesia provider were compared to 
BIS values, absent ETCO2 waveforms, and SpO2 values (see Tables 6 and 7).  
 The last data subjected to statistical analysis included the subject's PS 
classification and the lowest BIS value obtained during the endoscopy procedure.  This 
was accomplished via the Kruskal-Wallis test, a nonparametric test which makes no  
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Figure 14. Correlation graph demonstrating the relationship found between the patient's BMI  
and the patient's lowest BIS value observed throughout the procedure. r = .54. r2 = .29. p < .001. 
BIS = bispectral index; BMI = body mass index. 
*p < .05 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Correlation graph demonstrating the relationship found between the patient's BMI  
and the number of minutes the patient experienced BIS values ≤ 60. r = -.42. r2 = .17. p = .008. 
BIS = bispectral index; BMI = body mass index. 
*p < .05 
 
assumptions about the distribution of data within categorical groups.  This test is ideal for 
comparing three or more groups when data is ranked numerically (e.g., patients' lowest 
BIS value observed throughout procedure) and compared to a categorical data set or 
group assignment (e.g., PS I, II, III) (Lomax, 1998; Norman, 1999).  Consequently, the 
Kruskal-Wallis test was used to compare PS I, II, and III with the patients' lowest BIS 
value observed throughout the procedure.  This statistical test assigns a rank to all values 
in each group, sums and averages the rank values for each group, and then calculates a  
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Figure 16. Correlation graph demonstrating the relationship found between the patient's BMI  
and the number of minutes the patient experienced BIS values ≤ 40. r = -.51. r2 = .26. p < .001. 
BIS = bispectral index; BMI = body mass index. 
*p < .05 
 
Table 5 
 
Summary of Body Mass Index (BMI) Correlations 
  
Correlation BMI 
versus 
lowest 
BIS 
BMI 
versus 
minutes 
BIS ≤ 60 
BMI  
versus 
minutes  
BIS ≤ 40 
BMI 
versus 
minutes 
BIS ≤ 20 
BMI 
versus 
minutes 
SpO2 ≤ 90 
BMI versus 
minutes of  
absent 
ETCO2a 
   r                       .54        -.42                   -.51        -.30                 .06                 -.25                    
                                      
   r2                     .29                 .17                    .26         .09                 .00           .06      
                 
    p           <.001*      .008*             <.001*         .067               .728          .143 
_____________________________________________________________________________ 
Note. BIS = bispectral index; SpO2 = saturation of peripheral oxygen; ETCO2 = end tidal carbon dioxide 
aOnly 36 subjects were used to calculate all correlation and p values for absent ETCO2 due to no ETCO2 monitoring by  
one anesthesia provider in three patients. 
*p < .05 
 
Table 6 
 
Summary of Age Correlations 
   
Correlation Age  
versus 
lowest  
BIS 
Age  
versus 
minutes  
BIS ≤ 60 
Age 
 versus  
minutes  
BIS ≤ 40 
Age 
versus 
minutes  
BIS ≤ 20 
Age 
versus 
minutes  
SpO2 ≤ 90 
Age 
versus  
minutes of 
absent 
ETCO2a 
    r               -.06           -.23                 -.12           -.21                .15             .12                    
                                      
    r2                .00                 .05                   .01            .04                 .02             .01     
 
    p                .720         .156    .474            .197              .378            .500 
_____________________________________________________________________________ 
Note. BIS = bispectral index; SpO2 = saturation of peripheral oxygen; ETCO2 = end tidal carbon dioxide   
aOnly 36 subjects were used to calculate all correlation and p values for absent ETCO2 due to no ETCO2 monitoring by  
one anesthesia provider in three patients. 
*p < .05 
0 
5 
10 
15 
20 
25 
30 
35 
0 10 20 30 40 50 
M
in
ut
es
 B
IS
 ≤
 4
0 
   
BMI 
 
	   78 
Table 7 
 
Summary of Years as an Anesthesia Provider Correlations 
   
Correlation Years as 
provider 
versus 
lowest  
BIS 
Years as 
provider 
versus 
minutes  
BIS ≤ 60 
Years as 
provider  
versus  
minutes  
BIS ≤ 40 
Years as 
provider 
versus 
minutes  
BIS ≤ 20 
Years as 
provider 
versus 
minutes  
SpO2 ≤ 90 
Years as 
provider 
versus  
minutes of 
absent  
ETCO2a 
    r               -.26            .31                  .13            .08                -.19            .16                    
                                      
    r2                .07                 .10                  .02            .01                 .04            .02     
 
    p               .107         .056   .443            .645               .244            .360 
_____________________________________________________________________________ 
Note. BIS = bispectral index; SpO2 = saturation of peripheral oxygen; ETCO2 = end tidal carbon dioxide 
aOnly 36 subjects were used to calculate all correlation and p values for absent ETCO2 due to no ETCO2 monitoring by  
one anesthesia provider in three patients. 
*p < .05 
 
number representing the difference between the groups' mean ranks to determine if the 
samples are likely to be from the same group (Lomax, 1998; Norman, 1999).  For 
clarification, the calculated Kruskal-Wallis number is not the value that is cardinal to a  
researcher's assessment of gross differences in data sets; actually, it is the derived p 
value.  If significance is found in the difference between the groups' mean ranks, the null 
hypothesis (i.e., the mean rank values in each group are the same) can be rejected, 
suggesting there is a difference between at least two of the groups (Norman, 1999; Petrie 
& Sabin, 2000).  Therefore, significance demonstrated for this test (p = .037) implies 
there is a difference between at least two of the following groups: PS I, II, and III (see 
Figure 17). 
 Additionally, the Kruskal-Wallis test was used to compare the survey respondents' 
years of experience with providing anesthesia for colonoscopies to BIS values, absent 
ETCO2 waveforms, and SpO2 values.  Years of experience with colonoscopies was 
categorized into four intervals (i.e., 0-2, 3-5, 6-10, and > 10 years).  No statistical  
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Figure 17. Bar graph demonstrating the mean patients' lowest BIS value observed throughout 
the procedure for each Physical Status classification. The population standard deviation is 
represented by the error bars. Kruskal-Wallis statistic = 6.58. p = .037. BIS = bispectral index. 
* p < .05 
 
significance, determined by p < .05, was demonstrated for any variables when compared 
to the anesthesia providers' experience with colonoscopies (see Table 8).  Thus, the null 
hypothesis (i.e., the mean rank values in each group are the same) cannot be rejected, in 
that there is no apparent difference among the various years of experience groups (i.e., 0-
2, 3-5, 6-10, and > 10 years) when being compared to each dependent variable (e.g., 
lowest BIS, minutes of BIS ≤ 60).  In addition, these tests results should be viewed with 
caution due to the small sample size of the four categories used (Norman, 1999). 
Table 8 
 
Summary of Survey Respondents' Years of Experience Providing Anesthesia for Colonoscopies 
   
Kruskal-
Wallis  
test 
Years of 
experience 
versus  
lowest  
BIS 
Years of 
experience 
versus 
minutes  
BIS ≤ 60 
Years of 
experience 
versus 
minutes  
BIS ≤ 40 
Years of 
experience 
versus 
minutes  
BIS ≤ 20 
Years of 
experience 
versus 
minutes  
SpO2 ≤ 90 
Years of 
experience 
versus  
minutes of 
absent 
ETCO2a 
Statistic             2.76                 5.26                1.61            4.76                 0.45               0.65   
 
     p             .252        .072                .446            .092       .800               .722 
_______________________________________________________________________________ 
Note. BIS = bispectral index; SpO2 = saturation of peripheral oxygen; ETCO2 = end tidal carbon dioxide 
aOnly 36 subjects were used to calculate all correlation and p values for absent ETCO2 due to no ETCO2 monitoring by  
one anesthesia provider in three patients. 
*p < .05 
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CHAPTER FIVE:  DISCUSSION 
 
 
 The purpose of this study was to evaluate sedation levels via BIS monitoring in 
patients undergoing colonoscopies.  Moderate sedation is defined as a drug-induced 
depression of consciousness during which patients respond purposefully to verbal 
command (with or without light tactile stimulation) and are able to maintain a patent 
airway without intervention, sustain adequate spontaneous ventilation, and usually 
maintain their cardiovascular function (ASA, 2009);	  and according to the ASGE, this 
level of sedation is common and considered adequate for colonoscopy procedures 
(ASGE, Standards of Practice Committee, 2008).  In addition, some studies have shown 
that a BIS value of 80 correlates with what has been described as an “ideal” level of 
sedation for colonoscopies (Bell et al., 2004; Bower et al., 2000).  We hypothesized that 
levels of sedation in patients receiving anesthesia for colonoscopy procedures are deeper 
than what is suspected or intended.  A convenience sample of 39 patients having 
colonoscopies performed in a hospital-based outpatient setting and undergoing sedation 
with propofol, were included in this observational study.  Propofol was administered via 
intermittent boluses in 37 out of 39 (94.9%) patients and by bolus followed with infusion 
in 2 out of 39 (5.1%) patients; no patient received fentanyl or midazolam.  It was found 
that 100% (39/39) of patients reached levels of GA at some point during their procedure.  
The amount of time patients spent at this level of anesthesia ranged from 11.1-100% of 
their procedure.	  	  This range was surprising in that during the study all patients were found 
to be consented for IV GA.  The variables that showed a significant correlation with the 
occurrence of GA (i.e., BIS ≤ 60) were smaller BMI (p = 0.008), length of procedure (p < 
0.001), with longer procedures correlating with more time spent in GA, and the number 
 
	   81 
of minutes with absent ETCO2 (i.e., apnea) waveform (p = .002).  Additionally, data 
analysis suggested that patients with a larger BMI (compared to patients with lower 
BMIs) were more likely to have the greatest nadir in recorded BIS value (see Figure 14).  
Similarly, the r values suggest the greater the BMI, the fewer number of minutes patients 
experienced BIS values ≤ 60 and ≤ 40 (see Figures 15 and 16).  Thus, overall in our 
study, patients with larger BMIs tended to exhibit higher BIS values.  Studies involving 
BIS with this endoscopic patient population where anesthesia services are provided have 
not been previously performed. 
 Closed claims analysis of anesthesia injuries has shown that 10% of all allegations 
since 2000 have included “MAC” sedation (Metzner, Posner, Lam, & Domino, 2011).  
Since 1990, over 40% of all claims involving MAC sedation resulted in death or 
permanent brain damage.  Respiratory complications following “over sedation” with 
opioids or other sedative drugs was contributory in 21% of these cases, and it was shown 
that over half could have been prevented with better monitoring, such as continuous 
ETCO2 and pulse oximetry (Bhananker et al., 2006).  Of note, the ASA in 2011(a) stated 
that all patients receiving “anesthesia” should have oxygenation, ventilation, and 
circulation monitored, and that body temperature should also be assessed if clinically 
significant changes are anticipated.  Furthermore, deep sedation is defined as a drug-
induced depression of consciousness during which patients cannot be easily aroused but 
can respond purposefully to repeated or painful stimulation; independent ventilatory 
function may be impaired, airway assistance may be required to maintain airway patency, 
and spontaneous ventilation may be inadequate, but cardiovascular function is usually 
maintained.  Reaching deep levels of sedation during MAC with IV sedation can lead to 
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respiratory complications (ASA, 2009; Bell et al., 2004; El Chafic et al., 2012; Hata et 
al., 2009;	  Patel et al., 2005; Soto et al., 2005).  Noteworthy in our study was that severe 
respiratory complications (i.e., those requiring advanced airway interventions, such as 
placement of an LMA or ETT) were not observed, regardless of the sedation level.  
However, our sample size was small, and one of the limitations of the study was that it 
only included patients scheduled for elective colonoscopies.  We recommend future 
studies to include the monitoring of sedation levels in patients consented for MAC with 
IV sedation for other types of procedures, including those in outpatient centers as well as 
in hospitals. 
 Largely, our data indicated that administration of propofol for elective 
colonoscopies by anesthesia providers results in GA (100% experienced GA for at least 1 
minute).  In this study, no harmful adverse events were observed (e.g., respiratory or 
cardiac arrest, unresolved hypotension or hypoxia, aspiration resulting in admission to the 
hospital).  We suspect this was because 50% (6/12) of the anesthesia providers indicated 
via a survey (see Appendix H) that they believed they would be delivering GA 
throughout the entire procedure, and all providers (including those that did not believe 
they would be administering GA) were skilled in the management of GA; this 
demonstrates that it is probably safe for GA to occur during an elective colonoscopy by 
an anesthesia provider.  
 Hypoxia (i.e., SpO2 < 90%) can be a complication that occurs with deeper levels 
of sedation	  (Bell et al., 2004; El Chafic et al., 2012; Hata et al., 2009; Patel et al., 2005; 
Soto et al., 2005).  Several chin lifts were witnessed in response to hypoxia (SpO2 < 90%) 
and apnea (absence of ETCO2 waveform) throughout the data collection period, and 
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surprisingly some anesthesia providers were observed administering a chin lift without 
physiological evidence of the need for this action.  Therefore, the number of chin lifts 
that were required to maintain a patent airway could not be accurately determined, and 
this could explain why an absent ETCO2 waveform (i.e., apnea) was shown to have a 
significant correlation with IV GA, but not the number of minutes patients had a SpO2 ≤ 
90% (i.e., desaturation).  Furthermore, one patient required a jaw thrust after a chin lift 
was not effective and another patient was believed to have had a laryngospasm following 
possible aspiration of secretions.  This latter patient had a decrease in SpO2 to 87% for 1 
minute followed by a fall to 84% for a duration of 2 minutes.  Simultaneously, this 
patient was coughing and gagging, and subsequently, required suctioning.  Return to 
baseline SpO2 occurred within 1 minute after suctioning.	  	  No patients required advanced 
airway interventions, such as placement of a nasopharyngeal airway, oropharyngeal 
airway, face mask, non-rebreather mask, bag mask, LMA, or endotracheal tube.  Of note, 
20.5% (8/39) of patients in our study were found to be current smokers.  However, no 
patients were documented as using oxygen at home, and none had a history of previous 
airway surgery or known serious respiratory comorbidities (e.g., obstructive sleep apnea, 
emphysema, lung cancer, pulmonary hypertension). 
 Six patients experienced hypoxia for at least 1 minute and three patients for at 
least 2 minutes.  Of the three patients with at least 2 minutes of hypoxia, two had a 
decrease in SpO2 to 84% for at least 1 minute each.  All except one of the patients with at 
least 2 minutes of hypoxia had no ETCO2 waveform at the time of hypoxia, and each of 
them required a chin lift or jaw thrust to improve their SpO2 and achieve an ETCO2 
waveform on the monitor.  Out of a total of 656 minutes of data recorded for all 39 
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patients, a total of 51 minutes of absent ETCO2 (7.9%) was noted (see Figure 2).  
Propofol was the only drug used for sedation during all of the colonoscopies from which 
this data was obtained.  The frequency of hypoxia, absence of an ETCO2 waveform, or 
both, that required airway intervention in this study, demonstrates that administering 
propofol in the absence of an anesthesia provider could be unsafe.  
 There is a predicted increase, by 2015, in anesthesia professionals delivering 
sedation for over 50% of all colonoscopies (Inadomi et al., 2010).  However, in some 
endoscopy centers across the United States, nurses administer propofol sedation for 
endoscopy under the direction of a gastroenterologist.  This practice is advocated by 
some who maintain that MAC with IV sedation does not result in an increased safety for 
routine endoscopic procedures in average-risk patients (Rex et al., 2009).  As mentioned 
previously, we obtained one preoperative BIS value and then began recording BIS values 
every minute starting just after the first BP was taken in the endoscopy suite.  However, 
with some cases, several minutes would pass before the endoscopist team was ready for 
the start of the colonoscopy and before sedation was administered; this delay necessitated 
the elimination of recorded BIS values during this interval.  Therefore, only BIS values 
documented from the onset of the endoscopic procedure - within 1 to 3 minutes after the 
initial propofol bolus in most patients - were used for statistical analysis.  Out of a total of 
674 recorded BIS values, 512 (76%) were ≤ 60 (i.e., GA).  This indicates that after the 
first bolus of propofol (dose not recorded on anesthesia record) most patients reached GA 
and remained at a GA level of sedation for the majority of their procedure.  Therefore, it 
is possible that nurses who provide sedation with propofol during endoscopy procedures 
may unknowingly achieve a general anesthetic state, which is not in adherence to current 
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recommendations from the ASA (2011b) and Hospira (2009).  There have been two 
studies evaluating nurse-administered propofol sedation (Drake et al., 2006; El Chafic et 
al., 2012).  Of note, during the Drake et al. study, all patients were administered an initial 
40 mg propofol bolus followed by incremental boluses of 10-20 mg, with a total average 
rate of 15.8-17.2 mg/min; however, the study from El Chafic et al. did not provide the 
average doses of propofol administered, and neither study specifically evaluated the level 
of sedation produced via BIS monitoring.  Our study was limited to sedation administered 
by anesthesia personnel in patients consenting for IV GA.  Since patients were consented 
for GA, it is possible the anesthesia providers did not intend to maintain a lighter level of 
sedation during any portion of the colonoscopy procedures.  We recommend a future 
study using similar methodology to evaluate nurse-administered propofol sedation.  
 Since GA occurs frequently with sedation for colonoscopies, and given the pre-
study clinical observation and literature finding of colonoscopy patients being 
increasingly consented for MAC with IV sedation (Cohen & Benson, 2009; Cohen et al., 
2006; Inadomi et al., 2010; Rex, 2011; Siddiqui, Shafiq, & Asghar, 2012; Trummel, 
2007), a closer look at informed consent practices may be needed.  MAC was defined in 
2008 by the ASA as including varying levels of sedation, but when consciousness and the 
ability to respond purposefully is lost, GA is said to have occurred.  If patients are 
receiving GA, but are consenting for MAC with IV sedation or simply “MAC”, then their 
informed consent would not accurately reflect the level of sedation actually obtained.  
Anesthesia consent forms presented to patients typically include the type of anesthesia to 
be administered (e.g., IV GA, MAC with possible GA, MAC with IV sedation, moderate 
sedation).  
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 Survey responses from our study indicated that only one anesthesia provider 
believed they were delivering MAC 100% of the time, and 5 providers believed they 
were administering a combination of a MAC anesthetic and GA.  The remaining 50% 
(6/12) believed they were administering GA throughout 100% of the procedure (see 
Figure 5); however, responses may have been influenced by the fact that all patients 
undergoing elective colonoscopies at this one hospital were consented for IV GA.  It is 
likely anesthesia departments that opt to consent patients for IV GA may recognize the 
potential medical-legal concerns with obtaining consent for a different level of sedation 
than is actually being provided.  The guidelines for obtaining informed consent are clear 
in that patients must understand the risks and benefits of the prescribed treatment as well 
as alternative approaches (e.g., GA, MAC with IV sedation) before giving his or her 
consent (Berg et al., 2001; K. Feld & A. Feld, 2010).  Understandably, there is an 
increased risk for adverse events with deeper levels of sedation, and those risks should be 
disclosed when obtaining informed consent for any procedure, including colonoscopies.  
Furthermore, it is generally known that there is a high incidence of litigation in healthcare 
(U.S. Department of Health and Human Services, 2003), which further emphasizes the 
necessity of obtaining an appropriate consent by anesthesia providers.  In addition, 
adequate informed consent can assist jurors in deciding the validity of some allegations 
(Sanford, 2006). 
 National health care reform is in the process of being implemented and revised.   
As such, the secondary changes to Medicare that may ensue remains uncertain, including 
the impact on reimbursement for anesthesia services.  The future changes to Medicare 
reimbursements are important because Medicaid and other large private insurers often 
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follow Medicare policies (Rohlfsen & Sullivan, 2006).  In regards to reimbursement 
requirements, the CMS (2011a) requires during MAC procedures, close monitoring of the 
patient, since GA may be required for the treatment of adverse events (e.g., excessive 
pain, difficulty breathing, adverse reactions), and because of the potential for other 
unanticipated complications, such as a more extensive procedure with necessary 
anesthetic interventions.  Furthermore, the CMS (2011a) requirements for MAC and GA 
include the following: performance and documentation of pre and post-anesthetic 
evaluations, formation of an anesthetic plan, completion of an anesthesia record, and 
administration of necessary medications.  If all of these requirements are met with MAC 
procedures, reimbursement is stated to be the “same amount as allowed for full GA” 
(CMS, 2011a).  However, this CMS reimbursement policy could understandably change 
with the recent implementation of the Affordable Care Act.  
 This study has confirmed that GA occurs frequently during elective colonoscopies 
in patients who are consented for GA; therefore it is probable that GA also occurs with 
other endoscopic procedures in patients who are consented for MAC or MAC with IV 
sedation when similar doses of propofol are used.  Thus, this study may help provide 
noteworthy clinical data during the current implementation of health care reform; for 
modifying existing billing procedures (that may change) for colonoscopies that are 
commonly scheduled for a MAC anesthetic but may actually be performed under GA.  
 As stated earlier, it is important to note that all participants in this study were 
consented for IV GA, not MAC or MAC with IV sedation.  The investigators recognize 
the limitation this places on the external validity of this study, and recommend that future 
studies include patients consented for MAC or MAC with IV sedation.  
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 In conclusion, this study evaluated sedation levels via BIS monitoring during 
elective colonoscopy procedures when propofol sedation was administered by an 
anesthesia provider.  All patients received sedation levels equivalent to GA during their 
procedure.  Factors that correlated with greater time spent in GA were smaller BMI, 
longer length of the procedure, and minutes with an absent ETCO2 waveform.  
Additionally, the lowest BIS value obtained throughout the entire procedure was greater 
in those patients with a higher BMI.  The frequency of apnea correlated with length of 
procedure, but these findings were clinically insignificant since they did not result in a 
sustained decrease in SpO2 for any patient.  Serious complications (e.g., unresolved 
hypoxia, cardiac arrest, CVA, death) did not occur during the conduction of this study, 
and no relationship was found between the survey respondents' number of years as an 
anesthesia provider or years of experience with colonoscopies when compared to BIS 
values, absent ETCO2 waveforms, or SpO2 values (see Tables 7 and 8).  The results of 
this study indicate, in patients scheduled for colonoscopies who are consented for IV GA, 
it is common for anesthesia providers to consistently deliver a level of sedation 
concordant with GA.  The significance of this finding relates to the pre-study clinical 
observation, that endoscopic patients being consented for anesthesia designated as MAC 
with IV sedation actually demonstrate intraoperative signs of GA similar to what were 
observed in this study.  Future studies are warranted to determine the frequency of the 
various forms of anesthesia consent obtained for elective colonoscopies, along with 
research that assesses anesthetic depth with BIS monitoring in patients consented for 
MAC with IV sedation.  Such research would help to further enhance patient safety and 
address potential medical legal concerns. 
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APPENDIX A: OBSERVER’S ASSESSMENT OF ALERTNESS/SEDATION 
(OAA/S) 
 
 
o 0 = does not respond to noxious stimuli 
o 1 = does not respond to mild prodding or shaking 
o 2 = responds only after mild prodding or shaking 
o 3 = responds only after name is spoken loudly or repeatedly, or both 
o 4 = lethargic response to name spoken in a normal tone 
o 5 = responds readily to name spoken in a normal tone 
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APPENDIX B: MODIFIED OBSERVER’S ASSESSMENT OF 
ALERTNESS/SEDATION (MOAA/S) 
 
 
o 0=unresponsive to deep stimuli 
o 1=unresponsive to shaking 
o 2=responsive to shaking only 
o 3=responsive to loud verbal command 
o 4=lethargic response to normal verbal command 
o 5=responsive & alert 
o 6=agitated 
• Deep Sedation defined as ≤1 
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APPENDIX C: RAMSAY SEDATION SCORE (RSS) 
 
 
o Awake 
§ 1. Patient anxious and agitated or restless or both 
§ 2. Patient co-operative, orientated and tranquil 
§ 3. Patient responds to verbal commands only 
o Asleep; response to a light glabellar tap or loud auditory stimulus 
§ 4. Brisk response 
§ 5. Sluggish response 
§ 6. No response 
o Interpretation 
§ 1: Inadequate sedation 
§ 2-4: Acceptable sedation 
§ 5-6: Excessive sedation 
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APPENDIX D: PARDEE IRB LETTER 
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APPENDIX E: WCU IRB LETTER 
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APPENDIX F: PATIENT INFORMED CONSENT 
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APPENDIX G: ANESTHESIA PROVIDER INFORMED CONSENT 
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APPENDIX H: CRNA SURVEY FORM 
 
 
Survey of CRNAs participating in Colonoscopies 
Date: __ /__ /___ 
CRNA ID: _______ 
1. What year did you become a Certified Registered Nurse Anesthetist?  ________ 
2. Highest degree obtained? (Check one) 
 Diploma 
 Bachelors 
 Masters 
 Doctoral 
3. How many years or months of experience have you had with colonoscopies? (Check 
one) 
 0-6 months 
 7 months – 1 year 
 1 -2 years 
 3-5 years 
 6-10 years 
 More than 10 years 
 
4. What percentage of colonoscopies do you believe you are providing the following 
levels of sedation? (Numbers must equal 100%) 
• MAC __________ 
• General Anesthesia __________ 
• Combination of MAC and General Anesthesia _________  
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APPENDIX I: DATA COLLECTION SHEET 
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